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Aging is a major risk factor for many chronic diseases, including cancer 
and cardiovascular disease. The resulting need to understand and alleviate 
age-related decline has led to pharmacological manipulation of age-related 
degeneration in many species, including the nematode Caenorhabditis 
elegans, one of the simplest whole-animal models. However, few such studies 
have examined the anti-aging effects of natural compounds found in fruits and 
vegetables. 
Apples are the number one source of phenolics in U.S. diets. Apple 
phytochemicals have been shown to have a variety of salubrious effects, 
including high antioxidant and antiproliferative activity and the modulation of 
several molecular targets. We treated C. elegans with apple extracts, and 
found that lifespan increased significantly by up to 39%. Healthspan was also 
significantly improved as measured by two biomarkers, lipofuscin and motility. 
Additionally, animals pre-treated with apple extracts were more resistant to 
stresses such as heat, UV radiation, paraquat-induced oxidative stress, and 
pathogenic infection, suggesting that cellular defense system functions were 
also improved. To find the mechanisms behind these improvements, we 
screened several mutants that affect lifespan via different pathways. 
Prolonged lifespan does not appear to be mediated by calorie restriction, 
insulin signaling, sirtuins, or germ line signaling. Instead, the effects are at 
least partly due to reduced oxidative stress, as indicated by the increased 
lifespan of the mev-1 mutant. We also observed an increased induction of the 
promoter activity of small heat shock protein hsp16.2, and a reduction of 
induction of the promoter activity of superoxide dismutase and glutathione-S-
transferase, two enzymes that attenuate excessive reactive oxidative species. 
This is consistent with the idea that apple extracts may protect against 
deleterious oxidative damage normally mitigated by sod-3 and gst-4, leading 
to a decreased need for this part of the endogenous antioxidant system.     
We propose that in C. elegans apple phytochemicals act through a 
synergistic mechanism that involves attenuation of ROS damage, in particular 
superoxide anions, and generalized detoxification of oxidation byproducts. In 
addition, increased induction of the promoter of hsp16.2 likely contributes to a 
general improvement of cellular detoxification and stress response, and 
explains improved survival under conditions of stress.
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CHAPTER 1
Introduction: Health impacts of phytochemicals
Epidemiological studies have consistently shown a wide variety of 
health benefits associated with a diet rich in plant foods, especially fruits, 
vegetables and whole grains (1-3). Phytochemicals, the bioactive plant 
compounds that are not essential for human nutrition, are believed to be 
responsible for many of these health benefits, including the prevention or 
treatment of chronic diseases (4). Besides normal upkeep and maintenance, 
plants produce many of these bioactive compounds to defend themselves 
against microbes and insects, and to ward off diseases. To date, more than 
5000 phytochemicals have been identified, and many remain unknown (5). 
The most common sources of phytochemicals in foods include fruits, 
vegetables, and grains (4). 
Phytochemicals can be classified into five major groups: phenolics, 
carotenoids, alkaloids, nitrogen-containing compounds and organosulphur 
compounds. The phenolics can be further subdivided into phenolic acids, 
flavonoids, stilbenes, coumarins and tannins. Flavonoids can be divided still 
further. Importantly, the flavonols and flavanols (catechins) are found in fruits 
and are known to have a wide variety of health benefits. Most notably, these 
compounds have been associated with a reduced risk of developing chronic 
diseases such as cancer, cardiovascular disease (CVD), diabetes, Alzheimer’s 
disease, cataracts and other age-associated maladies (6-9). 
Phytochemicals possess a wide range of biological activities. These 
include antioxidant activity (e.g. scavenging of free radicals), inhibition of cell 
proliferation (e.g. inhibition of HepG2 liver cancer cells by apple extracts), 
inhibition of cell differentiation (e.g. arrest of MCF-7 breast cancer cells in G1/
1
S phase by apple extracts), inhibition of oncogenes (e.g. inhibition of AP-1 
tumor promotion protein by apple extracts) and induction of phase II enzymes 
(e.g. the induction of glutathione by sulforaphane, a phytochemical found in 
cruciferous vegetables such as broccoli) (10-13).
1.1.1 Evidence for prevention of cancer
Cancer is a group of diseases in which cells display uncontrolled 
growth, invasion of adjacent tissues, and sometimes metastasis. 
Carcinogenesis is a three-step process consisting of initiation, promotion and 
progression. During initiation, DNA undergoes damage by internal or external 
factors such as genomic instability and excessive reactive oxygen species 
(ROS) from cigarette smoke, UV radiation from the sun or polycyclic aromatic 
hydrocarbons (PAHs) from grilled or charbroiled foods (14). If the damage in 
the mutated DNA is not repaired, when the cell divides it multiplies along with 
the mutated DNA and the process enters the promotion stage, which is the 
clonal proliferation of mutated cells. During the third and final stage of cancer 
promotion, the mutated DNA affects the genes controlling proliferation, 
survival, which leads to malignancy. The first two stages, initiation and 
progression, are reversible, but the third stage, progression, is not. Once the 
cells become malignant, they can spread to other parts of the body and take 
over surrounding tissues in a process called metastasis. This is the deadliest 
aspect of the disease.  
Because cancerous tumors develop and sustain themselves by many 
different mechanisms, a variety of chemopreventative and chemotherapeutic 
approaches have been used. Among these are dietary phytochemical 
interventions whose role in chemoprevention has been well documented (10). 
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Block et al. reviewed close to 200 studies that examined the relationship 
between cancer risk and consumption of fruits and vegetables. In particular, 
the authors looked at cancer of the breast, ovary, colon, lung, cervix, 
esophagus, stomach, oral cavity, bladder and pancreas. In 128 of 156 studies, 
the authors found a significant protective effect with increased consumption of 
fruits and vegetables. In persons with a low consumption of fruits and 
vegetables, the risk of developing cancer increased by two-fold compared to 
those who consumed a high amount (15). Another prospective study looked at 
the flavonoid consumption of nearly 10,000 Finnish men and women and 
found that the risk of cancer incidence was inversely related to the number of 
fruits and vegetables consumed by the study participants (16). Of the major 
dietary flavonoids, those found in apples provided the greatest protection 
against lung cancer. In a population-based case-control study of women in 
Shanghai, pre-menopausal women who ate more dark yellow-orange 
vegetables and citrus fruits had lower incidence of breast cancer than those 
women who did not (17). Dietary phytochemicals have been shown to exert 
their chemopreventative effects by a variety of mechanisms. For example, 
they may affect DNA repair, carcinogen metabolism, cell proliferation, 
apoptosis, inflammation and antioxidation (10). To date, more than 1000 
phytochemicals have been shown to have chemopreventative properties (18). 
The mechanisms are cell-type or dose-dependent and often involve more than 
one target. For example, Epigallocatechin gallate (EGCG), a compound found 
in green tea, can inhibit carcinogen activation and DNA binding, as well as 
decrease CYP protein expression and AHR binding to DNA in HepG2 liver 
cells. Lycopene, a compound found in tomatoes and tomato products, was 
shown to influence the cell cycle by decreasing cyclin D1 and D3 expression 
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in human breast and endometrial cells, and increasing apoptosis in HL-60 
cells. Similarly, curcumin, a phytochemical from curry, has been shown to 
control the cell cycle and cell proliferation by decreasing the expression of 
cyclin D1 in prostate and breast cancer cells and also decreasing c-Jun and c-
Fos expression in mouse epidermal (JB6) cells. 
1.1.2 Evidence for prevention of heart disease  
Cardiovascular disease (CVD) is the number one cause of death and 
disability in the United States and around the world. CVD is a group of 
diseases and includes coronary heart disease (heart attacks), cerebrovascular 
disease, raised blood pressure (hypertension), peripheral artery disease, 
rheumatic heart disease, congenital heart disease and heart failure. The major 
causes of cardiovascular disease are tobacco use, an unhealthy diet and 
physical inactivity. 
Heart attacks and strokes are mainly caused by blockage that prevents 
blood from flowing to the heart or the brain. The most common reason this 
occurs is build-up of fatty deposits on the inner walls of the blood vessels that 
supply blood to these organs. As the blood vessels become narrower and less 
flexible (atherosclerosis), they are more likely to become blocked by blood 
clots. As a result, the proper amount of blood is not supplied to the heart and 
brain, and damage occurs. On a molecular level, excessive oxidation of low-
density lipoprotein (LDL) in the plasma and walls of the arteries may lead to 
their engulfment by macrophages and formation of foam cells. These cells line 
the arterial walls and lead to the formation of fatty streaks which progress to 
advanced lesions. The lesions restrict blood flow and lead to the different 
manifestations of CVD (19). 
4
Figure 1.1 Classification of dietary phytochemicals (adapted with permission 
from Liu, RH) (10).
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Numerous studies have suggested that phytochemicals play a role in the 
prevention of CVD, and diets that are rich in phytochemicals have been 
associated with a reduction in LDL, cholesterol and mortality from coronary 
heart disease. For example, dietary flavonoids have been inversely correlated 
with the risk of developing coronary artery disease and myocardial infarction. 
A study from Japan showed that flavonoid intake was inversely associated 
with total plasma cholesterol and low-density lipoprotein (LDL). Similarly, 
Joshipura and colleagues reported that a total intake of greater than 4 fruits 
and/or vegetables per day, was associated with a decreased risk of coronary 
artery disease (2). 
Mechanisms for the prevention of arteriosclerosis by phytochemicals 
with antioxidant properties have been proposed. In the LDL oxidation 
hypothesis, antioxidants consumed from food are incorporated into LDL and 
are themselves oxidized when the LDL are exposed to prooxidative 
conditions. Due to their reduced redox potential, the antioxidants prevent any 
extensive oxidation that may otherwise occur in the sterol or polyunsaturated 
fatty acids. Other potential mechanisms by which phytochemicals may prevent 
CVD include the reduction of platelet aggregation, modulation of cholesterol 
synthesis and absorption, and reduction of blood pressure. Increased 
inflammation is a strong predictor of cardiovascular disease (4). It promotes 
initiation and progression of atherosclerosis, and can also cause acute 
thrombotic complications that are associated with atherosclerosis. Many 
phytochemicals have antiinflammatory activity and thus may play an important 
role in the prevention of cardiovascular disease. For example, quercetin, 
which is found in apples and onions, has a range of antiinflammatory effects 
on prostaglandins, leukotrienes, histamine release and subsequent 
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antiasthmatic activity. Likewise, organosulfur compounds have been shown to 
have strong antiinflammatory effects. Chang and Chen found that nitric oxide 
(NO) and prostaglandin E2 (PGE2) production is inhibited by the garlic oil 
derivatives, diallyl sulfide (DAS), diallyl disulfide (DADS), and allyl methyl 
sulfide (AMS), in lipopolysaccharide (LPS)-activated RAW 264.7 macrophage 
cells (20).
1.1.3 Evidence for prevention of diabetes
Type 2 diabetes, also known as Diabetes mellitus, is a disease, 
characterized by high blood glucose levels, in which the body develops 
resistance to insulin and relative insulin deficiency. Type 2 accounts for 90% 
of all cases of diabetes. In the United States, there are an estimated 23.6 
million people living with the disease (21). At its onset, the disease can be 
managed by dietary modification and regular exercise, however as it 
progresses, pharmacological intervention is required.
 In a healthy individual under normal conditions, after food is consumed 
glucose is released into the bloodstream and stimulates the secretion of 
insulin by the pancreas. Insulin lowers blood-glucose levels by promoting 
glucose uptake by skeletal muscle and inhibiting hepatic gluconeogenesis. If 
there is a constant period of food intake, insulin secretion from the pancreas is 
also increased. This leads to accumulation of triglycerides in adipocytes and 
over time visceral obesity. In turn, factors such as free fatty acids (FFA) and 
tumour-necrosis factor-α (TNFα) inhibit insulin-mediated glucose uptake into 
skeletal muscle and inhibits hepatic gluconeogenesis. To prevent an increase 
in blood glucose, the pancreas increases insulin secretion, which results in a 
feed-forward cycle and leads to an altered metabolic state involving visceral 
7
obesity (22). Hyperglycemia (increased blood-glucose) and dyslipidemia 
(disruption of the amount of fatty acids and lipoproteins in the blood) can 
induce the inflammatory and oxidative stress responses, which leads to the 
generation of free radicals (23). In the case of type 2 diabetes, oxidative stress 
may block the action of insulin by impairing membrane fluidity, decreasing 
availability of nitric oxide (NO) or increasing intracellular calcium content. 
Multiple studies have shown that α- and γ-tocopherol, β- and α-carotene, 
lycopene, β-cryptoxanthin, lutein, zeaxanthin, retinol, as well as ascorbic acid 
are significantly decreased in diabetic individuals (24-26). Thus, the use of 
antioxidant therapeutics in the treatment of diabetes has been proposed (23). 
Flavonoids, carotenoids, ascorbic acid and tocopherols are the major 
groups of phytochemicals, which have been recommended due to their 
antioxidant and other health benefits (23, 27). These phytochemicals have 
been shown to inhibit free radical producing enzymes such as xanthine 
oxidase, cyclooxygenase, lipoxygenase, microsomal monooxygenase, 
glutathione-S-transferase, mitochondrial succinoxidase, NADH oxidase), 
chelating trace metals and inhibiting phospholipases A2 and C. The 
antioxidant mechanism of action is also mediated through donation of a 
hydrogen atom or electron to the many ROS radicals such as super-oxide 
anion, and hydroxyl, alkoxyl and peroxyl radicals, which protects lipoproteins, 
proteins and DNA molecules against oxidative damage. Other mechanisms by 
which phytochemical antioxidants may exert their effects are gene regulation, 
differentiation and apoptosis (23). 
Besides antioxidant activity, Sun and colleagues have shown that SIRT1, 
a histone deacytelase, improves insulin sensitivity by repressing PTP1B, a 
phosphatase, which reverses tyrosine kinase activity. The authors showed 
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that SIRT1 is downregulated in insulin-resistant cells and tissues and that 
knocking down SIRT1 induces insulin resistance. Moreover, overexpression of 
SIRT1 led to improved insulin sensitivity, especially under insulin-resistant 
conditions. Resveratrol, a phytochemical found in grapes and other plant 
foods, and an activator of SIRT1, was also found to improve insulin sensitivity 
in vitro in a SIRT1 dependent manner. When 2.5 mg/kg/day of resveratrol was 
administered to mice that were fed a high fat diet (which induces insulin 
resistance), the animals showed improved insulin sensitivity versus the 
control. The authors found that this effect was mediated via PTP1B at the 
chromatin level, and concluded that SIRT1 improves insulin sensitivity and 
could be useful in the treatment of insulin resistance and type 2 diabetes (28). 
1.1.4 Evidence for prevention of Alzheimer’s disease
Alzheimer’s disease (AD) is the most common cause of dementia in the 
elderly in the United States, and affects over 26 million people around the 
world (29). The clinical symptoms begin with memory impairment and 
progress to severe dementia. This process is brought about by the selective 
degeneration of nerve cells in the brain regions that are responsible for 
memory, cognitive performance and personality. The disease is characterized 
by the accumulation of amyloid beta peptide (Aβ1–42) aggregates and an 
increase in oxidative stress. One of the major hypotheses of AD is that the 
accumulation of amyloid beta deposits leads to downstream neurotoxic 
events, such as increased oxidative stress, which lead to neuronal dysfunction 
and death (30). Aksenov et al. suggested that protein oxidation is the major 
contributor to AD-associated neuron death and decline of cognitive abilities. 
Specifically, the oxidation of amino acid residues in proteins was suggested to 
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lead to loss of protein function (31). However, protein oxidation may not 
represent the whole picture. Schukitt-Hale and colleagues have shown that 
antioxidation is only one among many properties that predicted whether a 
particular plant food improved age-related changes in the brain . In one study, 
the authors fed rats with spinach, strawberry or blueberry supplemented diets, 
all of which had the same amount of antioxidant activity (as determined by the 
ORAC assay), and assessed the animals for cognitive behavior markers. The 
blueberry diet showed the greatest increases in motor performance, 
carbachol-stimulated GTPase activity, oxotremorine-enhanced DA release, 
and calcium recovery following exposure to oxidative stress. Since all of the 
extract-supplemented diets had the same amount of antioxidant activity, the 
authors concluded that antioxidation must not be the only factor that 
determines neuroprotective, anti-aging properties of phytochemicals. In a 
follow-up review, this group proposed that besides lowering oxidative stress, 
berry fruits could slow brain aging by lowering inflammation, modulating cell 
signaling involved in neuronal communication and neuroprotective stress 
shock proteins, and buffering calcium levels (33). Similarly, Casadesus and 
colleagues found that a diet supplemented with blueberries improved spatial 
memory and increased parameters associated with hippocampal neuronal 
plasticity, which correlates with improvements in spatial memory and cognitive 
performance (34). The authors examined a number of markers of hippocampal 
plasticity, including extracellular receptor kinase activation, and IGF-1 and 
IGF1-R levels in blueberry-supplemented aged animals. The results showed 
that all parameters were increased in supplemented animals. In addition, work 
done on C. elegans has shown that the soy isoflavone glycitein protects 
against beta amyloid-induced toxicity and oxidative stress (35). Transgenic 
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animals expressing the human amyloid beta peptide (Aβ1–42) were fed a diet 
supplemented with glycitein. These had reduced amounts of beta amyloid and 
hydrogen peroxide. The authors concluded that this isoflavone suppresses Aβ 
activity through antioxidant activity as well as inhibition of A  deposits. β
1.1.5 Evidence for prevention of eye aging
The eye also undergoes age-associated deterioration, which often 
manifests itself in diseases such as macular degeneration, glaucoma, 
cataracts and vascular degeneration. Ocular structure, function and blood flow 
all markedly deteriorate with age, as does visual acuity, contrast sensitivity 
and dark adaptation threshold (9). Moreover, there is a loss of retinal pigment 
epithelial cells and photoreceptors (36). Other pathophysiological changes 
with age include a decrease in the number of axons, a decline in retinal nerve 
fibers (which represents a loss of about 60,000 retinal ganglion cells per 
decade) and an increase in the susceptibility to damage to the retinal ganglion 
(9). In addition, during both aging and glaucoma, individuals experience a 
number of common symptoms including blood flow abnormalities, narrowing of 
blood vessels and endothelial dysfunction (9). 
Age-related macular degeneration is linked to oxidative stress, which is 
believed to be one of the mechanisms responsible for the aging changes in 
retinal pigment epithelial (RPE) cells. Lipofuscin, the photoreactive pigment 
that accumulates with age in many tissues, including eyes, contributes most of 
this oxidative damage to RPE cells. A recent study by Zhou et al. has shown 
that administration of sulforaphane, a phytochemical that induces phase 2 
enzymes to RPE cells, indirectly decreased oxidative damage and elevated 
levels of NAD(P)H:quinone reductase, and glutathione-S-transferases, phase 
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2 enzymes in these cells. The authors concluded that, in addition to 
carotenoids and antioxidant vitamins, plant-derived phase 2 inducers such as 
sulforaphane may also be important in the prevention or treatment of age-
related macular degeneration (37).
1.2 Classification and characterization of apple phytochemicals
Apples are the second most highly consumed fruit (after bananas) in the 
United States and the number one source of phenolics in American diets (38, 
39). According to the U.S. Department of Agriculture, the average adult 
consumes approximately 16 pounds of fresh apples per year. The health 
benefits of apples are in large part due to their unique phytochemical profiles. 
In particular, apples are a good source of phenolics compounds. Of these, the 
vast majority are in the flavonoids group (40). The total phenolic content has 
been estimated to range from 110 to 357 mg/100 g fresh apple (9, 10). Tsao 
et al. have reported that phenolics are five times more prevalent in the skin 
than the flesh of the apples (41). The nature and distribution of these 
compounds between the skin and the flesh is also different. Whereas the flesh 
contains catechins, procyanidins, phloridzin, phloretin, the skin has additional 
flavonoids such as quercetin glycosides and cyanidin glycosides (42). 
Among these compounds, several classes of phenolic antioxidants 
have been described. These include: cinnamates, flavan-3-ols, flavonols, 
procyanidins, dihydrochalcones, and anthocyanins (43).
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Table 1.1 Antioxidant activity of different apple varieties (adapted from Tsao et 
al.) (41)).
Apple Variety
Antioxidant Activity 
(Peel/Flesh)
(µM Vit. C Equiv.)
Phenolic Content
(Peel/Flesh)
(µg/G)
Red Delicious 4,112±13/2,192±4 2,012±20/358±12
Northern Spy 10,044±20/5,049±1 1,548±24/934±7
Ida Red 5,958±17/3,069±0 1,479±21/489±1
Cortland 4,133±16/1,629±1 1,323±21/498±11
McIntosh 5,531±23/2,967±1 1,163±17/488±10
Golden Delcious 5,223±11/2,192±4 1,265±22/417±15
Mutsu
 4,643±24/1,895±14 1,017±26/313±13
Empire 3,800±4/1,457±3 782±14/177±1
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Recently, research from our laboratory has identified 29 structurally diverse 
compounds from apple peels, many of them unique, using bio-guided
fractionation. The most prominent were quercetin-3-O-β-D-glucopyranoside, 
quercetin-3-O-β-D-galactoupyranoside, quercetin, catechin, epicatechin and
quercetin-3-O-α-L-arabinofuranoside (40). 
Tsao et al. found that, of the major polyphenols that they examined, two 
compounds, epicatechin and procyanidin B2, were the greatest contributors to 
total antioxidant activity. Of the eight varieties of apples examined, the Red 
Delicious variety had the highest antioxidant activity (41). In addition, 
procyanidins made up approximately 60 percent of the antioxidant activity in 
the peel and 56 percent in the flesh. The researchers concluded that: "When 
taste and texture do not matter, choosing an apple with a high proportion of 
polyphenols in the flesh and skin can potentially produce more-health 
benefits," and also that: "eating any apple is better than eating no apple at all."
The present study used the Red Delicious variety of apples for a 
number of reasons. First, this variety of apples is the most widely consumed in 
the U.S. and accounts for 27% of U.S. apple production (44). This variety also 
had the highest level of antioxidant activity among eight popular varieties of 
apples as shown above (41). Additionally, the effects and health benefits of 
Red Delicious apple phytochemicals have been well characterized in our 
laboratory (see discussion below). Overall, apples possess a wide range of 
biological health-promoting activities (38).
1.3 Absorption and metabolism of flavonoids
Flavonoids from apples are found mainly in the glycosylated form, 
attached to a sugar moiety. In humans as well as rats, upon entering the oral 
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cavity these compounds undergo hydrolysis and then are further hydrolyzed in 
the small intestine. The flavonoids such as quercetin are absorbed as 
aglycones. The vast majority of absorption occurs in the small intestine and 
colon through the microflora. The human intake of flavonoids is about 300-650 
mg/day. In terms of metabolism, a variety of phase I, p450 CYP enzymes are 
responsible for adding functional groups and activating flavonoids in 
preparation for uptake or excretion. For example, CYP1A2 as well as CYP2E1 
can efficiently oxidize several isoflavones. Whereas, phase II enzymes such 
as glucoronide sulfatase, as well as the bacterial enzymes UDP-
glucuronosyltransferase and sulfotransferase can convert the activated 
phytochemicals to flavonoid glucuronide and flavonoid sulfate. Other important 
players in the absorption of flavonoids are the sodium-dependent glucose 
transporter 1 (SGLT1) and multidrug resistance-associated proteins 2 and 3 
(MRP2 and MRP3), which are membrane transporters (45). 
Based on direct evidence, Hollman et al. have proposed that flavonoid 
glycosides actually could be absorbed intact in the small intestine, using the 
sodium-dependent glucose transporter (SGLT1) (46). On the other hand, it 
was shown that the efficiency of this absorption was suppressed by efflux of 
some of the flavonoid glycosides shown that by the apical transporter 
multidrug resistance-associated protein 2 (MRP2) (45). In addition, other 
evidence has shown that some flavonoid glucosides can be hydrolyzed in the 
oral cavity small intestine (47).  
1.4  Effects of apple phytochemicals: evidence from chemistry assays 
The antioxidant activity of apples has been well established in a variety 
of chemistry assays. Using the ABTS assay, Vieira et al. have shown that 
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within a variety of cultivars tested, the total phenolic, flavanol and anthocyanin 
contents and antioxidant activity were highest in the peels, followed by the 
whole fruit and the flesh. Total phenolic content was correlated strongly with 
total antioxidant activity in flesh, whole fruit and peel. The researchers 
concluded that phenolic compounds contribute a significant amount of 
antioxidant activity, and that this activity varies considerably depending of the 
part of the apple and cultivar analyzed (48). Similarly, Tsao et al. used a PCL 
assay to show that among the eight most popular apple varieties in the U.S., 
Red Delicious apples have the highest total antioxidant activity. The authors 
also found that apple peels have significantly more phenolics than does the 
flesh as was previously reported. Of the major phenolic compounds that were 
tested, epicatechin and procyanidin B2 contributed the highest antioxidant 
activity (41). 
1.5 Effects of apple phytochemicals: evidence from cell culture assays 
Cell culture experiments have demonstrated that apples possess strong 
antioxidant and antiproliferative activities. Studies from our laboratory have 
shown that apple extracts have potent antiproliferative activity against HepG2 
liver cancer cells and Caco-2 colon cancer cells (49). Notably, apples with 
peels had considerably more activity than apples without. In addition, the 
extracts also had strong antioxidant activity using the TOSC assay. 
Interestingly, Vitamin C contributed only a small percentage of this activity. In 
a follow-up study, Sun et al. surveyed 11 of the most commonly consumed 
fruits and found that apples had the second highest total antioxidant activity 
behind cranberries (50). Similarly, Wolfe et al. showed that among 25 of the 
most commonly consumed fruits, apples have the highest antioxidant activity 
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and are the number one contributor of phenolics (39). Others reports have 
also confirmed that apple phytochemicals possess potent antioxidant and 
antiproliferative activities in vitro. For example, He and Liu have shown that 2-
α-hydroxy-ursolic acid, one of the phenolic acids found in apple peels, has 
potent antioxidant and antiproliferative activity (51). In a follow-up report, these 
researchers isolated additional compounds from apple peels and showed that 
the flavonoids quercetin and quercetin-3-O-β-D-glucopyranoside had the 
highest antioxidant and antiproliferative activity among 29 structurally diverse 
compounds (40). 2-α-hydroxy-ursolic acid has also been shown to inhibit TNF-
α induced activation of NF-κB in MCF-7 cells in a dose dependent manner 
(52). Additionally, Red Delicious apple extracts have been shown to induce G1 
arrest and decrease the expression of Cyclin D1 and Cd4, and inhibit the 
tumor activator protein AP-1 (11, 12). Another study looked at the effects of 
apples, bananas and oranges on oxidative stress-induced damage to neuron 
like PC12 cells and found that these cells were protected against neurotoxicity 
after they were exposed to hydrogen peroxide treatment (53).
1.6 Effects of apple phytochemicals: evidence from animal studies  
Data from animal studies have confirmed that apple phytochemicals 
have potent anticancer effects in vivo. A study by Liu et al. showed that 
consuming the human equivalent of 1, 3 and 6 apples per day reduced DMBA-
induced incidence of mammary tumors in rats by 17, 39 and 44% respectively 
(54).
In a follow-up study, rats were administered whole apple extracts 2 
weeks prior to DMBA administration and continuing for 24 weeks. The animals 
developed mammary tumors with an incidence of 71.4%. In contrast, animals 
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that were pretreated with apple extracts showed a significantly reduced 
burden of mammary tumors in a dose dependent manner. In particular, the 
number of adenocarcinoma masses decreased with increasing apple extracts. 
In addition, the expression of proliferating cell nuclear antigen (PCNA), cyclin 
D1, and Bcl-2 decreased, and Bax expression and apoptosis all increased 
with increasing apple extracts (55). 
1.7 Effects of apple phytochemicals: evidence from epidemiology
Epidemiological studies have shown a correlation between the intake of 
fruits and vegetables and the incidences of cancer and cardiovascular disease 
(2, 15). Several studies have looked at apples or apple phenolics in particular. 
A few of these are reviewed below. 
In a recent retrospective case-control study, Jedrychowski and 
colleagues have shown that apple consumption is associated with a reduced 
risk of colorectal cancer (56). Colorectal or colon cancer is the third most 
prevalent cancer and the second most lethal cancer among all cancers in the 
Western World.  The authors interviewed a total of 186 colorectal cancer 
patients for whom information on histology, anatomic location and stage of 
cancer was available, and compared this with 211 noncancer controls from the 
same hospital taking into account confounding factors such as age, gender, 
place of residence, marital status and occupation. It was found that patients 
who consumed at least one apple per day had a reduced risk of developing 
colon cancer. Fruits such as citrus fruits and berries did not show such a 
correlation.  
Le Marchand et al. conducted a population-based retrospective case-
control study in Hawaii to look at the effect of diet on incidence of lung cancer 
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(57). In an in-person interview, the researchers assessed smoking history and 
intake of 242 food items for 582 patients with lung cancer and 582 controls 
who were matched for ethnicity, age, and gender. After adjusting for smoking 
and intakes of saturated fat and ß-carotene, it was found that there was a 
statistically significant inverse association between lung cancer risk and the 
major food sources of two flavonoids: quercetin, which is present in apples 
and onions, and naringin, which is present in white grapefruit. Interestingly, the 
authors found that squamous cell carcinoma was strongly modified by the 
CYP1A1 genotype and speculated that this might be due to the inhibitory 
properties of quercetin in subjects who consumed flavonoid-rich foods, as was 
reported previously.  
Sesso and colleagues examined the risk of flavonoid consumption and 
risk of cardiovascular disease (CVD) in women. 38,445 women were enrolled 
in a prospective study with a mean follow-up of 6.9 years. The researchers 
distributed a food-frequency questionnaire and analyzed the amounts of 
flavonoid consumption based on the reported flavonoid-rich food content. The 
mean flavonoid intake was determined to be 24.6 ± 18.5 mg/d, primarily as 
quercetin (70.2%). It was found that there was no significant difference 
between intake of flavonoids and CVD. It is worth pointing out that, both 
broccoli and apples were associated with a lower risk of CVD; however, these 
differences were not statistically significant. 
The conclusion from this study was that flavonoid intake is not strongly 
associated with a reduced risk of CVD. Moreover, there were no immediate 
inverse associations for broccoli, apples, and tea with CVD (58).
This is but a small sample of epidemiological studies that have been 
undertaken to gauge the relationship between the consumption of apples or 
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their phytochemicals and risk of chronic disease. As can be seen from some of 
these studies, apples and apple phytochemicals can effectively prevent the 
incidences of some types of cancer, but not of cardiovascular disease, at least 
in this study. However, given the overwhelming amount of epidemiological 
evidence, showing the health benefits of apple consumption suggests that 
there is at least some protective effect of apples when it comes to cancer, one 
of the leading causes of death in the United States and around the world. 
Other diseases against which showed that apples have a protective effects 
are asthma, chronic obstructive pulmonary disorder when compared to other 
fruits and vegetables that have a high polyphenol content. In addition, apple 
consumption was also associated with improved lung function (56). Therefore 
the overwhelming amount of evidence suggests that apple phytochemicals 
have a protective effect with regard to at least some chronic. While thus far, 
the strongest association appears to be between colon cancer and the 
consumption of apples, the association between apple consumption or 
flavonoids derived from apples is currently of great interest and being 
investigated. While the mechanisms of some of these have recently started to 
come to light, further research is most certainly needed to elucidate the 
relationship between apples and other types of cancers and diseases against 
which apples may have a protective effect, and the mechanisms underlying 
these effects. 
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Figure 1.2 Major phytochemicals found in apples. Groups, classes and single 
components of apples: (a) Phenolic (b) Flavonoid (c) Chlorogenic acid (d) 
Catechin (e) EGCG (f) Catechin
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1.8  Definition and theories of aging 
Aging is a nearly universal biological phenomenon that is influenced by 
a variety of endogenous and exogenous factors, which are governed by an 
organism’s genetic predisposition, its environmental setting, and stochasticity. 
In its broadest sense, it can be defined as a progressive deterioration of 
virtually every bodily function over time, resulting in an increasing susceptibility 
to environmental challenge and a growing risk of disease and death (59). In 
recent years, a great deal of progress has been made in identifying the 
underlying mechanisms and environmental conditions that influence aging, 
however many unanswered questions still remain. Although different species 
age at different rates, several recent studies have shown that lifespan may be 
controlled by a small number of conserved pathways and pharmacological 
manipulation of natural products and drugs (60, 61). The correlation between 
aging and incidences of chronic diseases has been well established in the 
literature (6). 
Many theories exist to explain the physiological deterioration that 
occurs in an organism over time. Among evolutionary theories of aging, the 
“disposable soma theory” and the “antagonistic pleiotropy” theory are the most 
regarded. Likewise, the classical “free radical theory of aging” and more 
recently the “green theory of aging” provide alternative explanations for how 
organisms accumulate various types of damage that can lead to aging. 
1.8.1 Free radical theory of aging
According to the Free Radical Theory of Aging, aging is a result of the 
accumulation of molecular damage caused by free radicals, highly reactive 
molecules that contain one or more unpaired electrons (62). Reactive oxygen 
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species (ROS), which are the most prevalent types of free radical oxidants, 
include superoxide anions, hydroxyl radicals, hydrogen peroxide, and peroxyl 
radical, and have been implicated in a number of degenerative and chronic 
diseases including cancer (63). In 1972, Harman refined the theory, 
suggesting that superoxide anions produced in the mitochondria are the major 
agents of damage that lead to the aging phenotype (64).
Free radicals emanate from both internal and external sources. Major 
endogenous sources of free radicals include the mitochondrial electron 
transport chain, peroxisomal fatty acid synthesis, metabolism of xenobiotics 
via oxidation/reduction of cytochrome P450, reaction with nitric oxide, as well 
as inflammation associated with pathogenesis (63). External sources include 
air pollution, ionizing radiation, and exposure to chemicals. Under normal 
physiological conditions, a cell’s internal environment is maintained in a state 
of homeostasis in which there is a balance between oxidants and antioxidants, 
substances that scavenge free radicals. When the production and leakage of 
oxidants overwhelms the amount and scavenging capacity of antioxidants, 
oxidative imbalance occurs, resulting in molecular damage to DNA, proteins 
and lipids. While the Free Radical Theory of Aging accurately predicts the 
damage and deterioration that is caused by free radicals over time, evidence 
thus far only exists for a correlation between the accumulation of this damage 
and ROS production and no direct link to causation of aging has ever been 
established (65, 66). This has caused some to question its validity as a viable 
explanation for the aging process. In particular, several groups have recently 
published reports that contradict some of the theories predictions. For 
example, the deletion of some or all of the superoxide dismutases present in 
C. elegans, appears to have no effect on lifespan, yet still decreases oxidative 
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damage (67, 68). Some groups have suggested that it may be time to rethink 
the theory’s tenets by building rather than setting aside its predictions. One 
such theory is the “green theory of aging.” 
1.8.2 Green theory of aging 
According to the Green Theory of Aging, toxic byproducts of metabolism 
accumulate within the cell and lead to aging. These byproducts arise as a 
result of initiating events, including (but not limited to) ROS, UV radiation, and 
a variety of stochastic perturbations that lead to the formation of a wide range 
of secondary deleterious and toxic metabolites and cause biochemical 
damage within the cell. Examples of byproducts that are generated and 
broken up within the cell are lipofuscin, Advanced Glycation End-products 
(AGEs) and byproducts of oxidation such as lipid peroxidation debris and 
cross-linked proteins. Likewise, substances that enter the organism from 
outside, such as those found in food, drugs (in humans), and chemicals found 
in the environment, need to be metabolized in order to be eliminated. The 
system of enzymes that is responsible for performing this metabolism consists 
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Figure 1.3 Formation of free radicals (adapted from Liu, RH presentation)
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of Phase I enzymes, in particular those in the P450 family, and Phase II 
enzymes such as glutathione. Phase I enzymes add functional groups to 
make the chemical bioactive, usually by hydroxylation, and to prepare it to be 
conjugated by Phase II enzymes, which make them insoluble and allow their 
removal from the body. Thus, metabolism and excretion of toxic endobiotic 
and xenobiotic metabolites is the key to keeping the cellular environment junk 
free and to promoting longevity. However, the process of constantly “cleaning 
out” molecular junk is energetically costly, therefore a cell must carefully 
budget its resources and sometimes cannot carry the cleaning out even when 
it is necessary. As an organism ages, it accumulates more and more 
molecular junk, which becomes increasingly energetically costly to remove. If 
left inside the cell, this junk accumulates until it starts reacting within and 
causing deleterious damage to the cell. However, fitness may be optimized by 
investing only the minimum resources required into somatic maintenance 
processes, to increase the chances of survival through reproduction (69). 
There are several lines of evidence to support this theory. McElwee et 
al. have shown that in microarrays studies of IIS and dauer nematodes, there 
is an enrichment of gene classes that code for cytochrome P450, short-chain 
dehydrogenase/reductase, UDP- glucuronosyl transferase, and glutathione S-
transferase (70). The genes are mainly involved in the detoxification of toxic 
molecular rubbish. Similarly, according to Ayyadevara et al. a subset of 
glutathione-S-transferases (GSTs), which are Phase II enzymes, is 
overexpressed in the long-lived IIS mutant. In addition, life extension is fully 
reversed upon deletion of CeGSTP2-2 (a particular type of GST) expression 
(71). The green theory of aging is complementary to the disposable soma 
theory discussed below.
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1.8.3  Disposable soma theory of aging
According to the disposable soma theory of aging, an organism must 
allocate resources between maintenance of somatic tissues and reproduction, 
which results in a trade-off between longevity and reproductive fitness (72). 
Interestingly, longevity assurance genes, of which detoxification genes are a 
major subset, are also energetically costly because they are required for the 
maintenance of the soma. In the wild, an organism is faced with a finite food 
supply, and must decide whether to expend resources for food energy and 
metabolism, or to save them for reproduction. If more resources are spent on 
reproduction at the expense of maintaining one’s own soma, the organism 
would shorten its own lifespan. In contrast, if the organism allocates fewer 
resources to reproduction and spend more energy on its own maintenance, it 
will increase its chances of survival.  While it makes sense from an 
evolutionary perspective for organisms that must survive in the wild, this 
theory has been called into question by a number of laboratory studies in C. 
elegans, which have shown that organisms can live longer with no effect on 
reproduction, and that reproductive capacity is reduced without affecting 
lifespan (73). Interestingly, other studies in C. elegans have shown that 
signaling from the germline and somatic gonad can have an effect on lifespan, 
without affecting reproductive capacity. 
1.8.4 Antagonistic pleiotropy theory of aging
According to the theory of antagonistic pleiotropy, genes that are 
beneficial early in life may have detrimental effects later in life and thus led to 
aging. In particular, those genes that are selected for before reproduction can 
have negative consequences when the organism is no longer reproductively 
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viable because from an evolutionary standpoint their original function has 
been fulfilled. Therefore, ironically, they would promote lifespan early in life 
while shortening it late in life (74). Several examples of such genes exist in the 
literature. One is tumor suppressor p53, which confers protection against 
cancer (and death) by preventing abnormal cells from continuing to proliferate. 
However, this ability to stop cell proliferation is deleterious if it interferes with 
the proliferation of normal cells, such as stem cells for example, which are 
needed by the organism for tissue renewal as it ages. A recent review by 
Ungewitter and Scrable suggests that at least one other gene that is evolving 
independently, SIRT1 is required in for p53 to exert its deleterious effects late 
in life (75). Another example is the hormone testosterone in human males. 
Higher levels of testosterone lead to increased fertility early in life while 
causing decreased fitness later in life because of a higher risk of prostate 
cancer early in life lead to increased fertility (76). 
Many other aging theories exist (59). However, evolutionary biology 
coupled with studies from model organisms and those in the wild, provides a 
useful framework against which to view such theories. Importantly, the role of 
molecular biology and model organisms in aging research is important in 
refining the major theories and enhancing our ability to understand the 
mysteries of the aging process. 
1.9 C. elegans as an aging model   
 C. elegans is a popular model system in aging research for a variety of 
reasons. Under standard laboratory conditions, the organism has a short 
generation time of approximately 14-21 days and is easy to grow and culture 
in the laboratory at temperatures ranging from 16ºC to 27ºC. Molecular 
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genetics methods have been well characterized and tested, and more than 70 
gerontogenes have been identified (77). Some, such as insulin signaling (see 
below), play a key role in mammalian regulation of age-related diseases. 
Additionally, worms and mammals share several common aging features. 
First, oxidative stress and the accumulation of reactive oxygen species and 
their byproducts have been shown to correlate with or contribute to aging and 
decrease lifespan in both humans and worms (78, 79). Second, calorie 
restriction, the only intervention that extends lifespan in mammals, extends the 
lifespan in C. elegans (80). Third, sarcopenia, the wasting away of muscle 
tissue is associated with the aging phenotype in both humans and worms (81). 
Additionally, as they age, both humans and worms undergo reproductive 
senescence and become infertile. The amount of information and informatic 
tools available for the molecular analysis of C. elegans is arguably the best of 
any model organism. In particular, the development of RNAi technology in C. 
elegans (for which Fire and Mello received the Nobel prize in 2006) to knock 
out genes and study their function has been an invaluable tool in aging 
research.
  Despite these useful features, some disadvantages also limit the 
worm’s utility as an aging model (77). The worm’s small size may prevent 
detailed biochemical and pathological study in some cases. Physiologically, 
the worm also lacks certain critical systems such as the immune system. 
Evolutionarily, C. elegans is quite far removed from mammals (hundreds of 
millions of years), which means that many critical human genes have no 
homologs and vice versa. Additionally, the worm is covered with a tough 
cuticle that is difficult to penetrate, which may make it a challenge to study 
drug response in certain cases. Despite these shortcomings, a substantial 
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body of scientific literature attests to the fact that C. elegans is an excellent 
model system to study aging (82, 83).
1.9.1 Aging mutants in C. elegans 
In C. elegans, a number of longevity pathways which shed light on the 
aging process been identified. The elucidation of these pathways has been 
facilitated by the production of long and short-lived mutants. Below is a 
summary of the major mutant categories and their effects on lifespan.
1.9.2  Insulin signaling pathway: role of DAF-16 in lifespan extension  
In C. elegans, the best-studied longevity pathway is the daf-
2/IGF/insulin signaling pathway also known as the IIS pathway. This pathway 
regulates dauer formation (a diapause state which the nematode enters in 
times of stress), development, stress resistance and lifespan. Mutation of daf-
2, the insulin-like receptor, extends C. elegans lifespan by up more than 2-fold 
(84). Interestingly, the lifespan extension of IIS mutants depends upon only a 
single transcription factor, daf-16, which regulates hundreds of downstream 
targets. daf-2 mutants are more resistant to many different types of stress, 
including oxidative, heat and UV stress and have improved fat storage and 
metabolism. DAF-16 is negatively regulated by DAF-2, a tyrosine kinase 
receptor that is the C. elegans insulin/IGF receptor ortholog. Upon binding of 
an insulin-like ligand, DAF-2 signals AGE-1, a phosphoinositol-3-kinase 
(PI3K), which in turn activates PDK-1 and AKT-1/AKT-2. When activated, 
AKT-1 and AKT-2 phosphorylate DAF-16, sequestering it from the nucleus. 
Therefore, only a very low amount of DAF-16 is normally present in the 
nucleus under normal, non-stressed conditions. However, in times of stress 
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(e.g. starvation, heat or overcrowding) DAF-16 is dephosphorylated and 
translocates into the nucleus. Here, it can bind to the promoter sequences of 
many genes that regulate stress response, including oxidative and heat shock, 
metabolism, fat storage and lifespan. Importantly, these genes can be both up 
and down regulated in response to DAF-16 binding. For example, the genes 
that code for the antioxidant enzymes SOD-3 and CTL-2 are upregulated, 
whereas yolk protein genes VIT-2 and VIT-5, as well as PEP-2, an 
oligopeptide transporter are downregulated (86). 
Studies on tissue specificity have revealed insulin signaling to be tissue 
specific. Wolkow et al. have shown that daf-2 or age-1 signaling from the 
neurons is sufficient to affect lifespan (87). In addition, Libina and colleagues 
have shown that overexpression of daf-16 in the intestine (where fat storage 
and metabolism take place), is sufficient to increase lifespan (88). Importantly, 
the insulin signaling pathway and its effects are conserved across species, 
including flies and mice. 
1.9.3 SIR2.1
Silent information regulator (SIR) proteins (also known as sirtuins), of 
which sir2.1 is a member, belong to a family of NAD+-dependent deacetylases 
that play an important role in gene silencing, DNA repair and aging in a 
diverse group of organisms (89). Sirtuins exert their major effects in the cell by 
removing acetyl groups from specific target proteins. This deacetylase function 
depends on the intracellular concentration of nicotinamide adenine 
dinucleotide (NAD), a molecule involved in metabolism. This molecule can 
exist in two states, oxidized and reduced. The oxidized form is the one that 
greatly enhances sir2.1 activity. In C. elegans, increased expression of sir2.1 
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has been shown to extend lifespan (90), and sir2.1 has been shown to both 
interact with and have distinct functions from daf-16, and has been proposed 
to be partly responsible for the increase in lifespan under caloric restriction 
(91). Small molecules that affect sir2.1’s enzymatic activity have been 
identified. Among these is resveratrol, a phytochemical that is found in a 
variety of plants. It has been shown that resveratrol extends lifespan in C. 
elegans in a manner that is dependent on sir2.1 but independent of daf-16 
(92).
1.9.4 Oxidative stress mutants
In C. elegans, oxidative stress and the free radical theory of aging 
(discussed in the previous section) have been a subject of great study and 
much contention. While initial evidence seemed to indicate that oxidative 
stress and aging may have a causal link (93-95), several recent studies have 
called this hypothesis into question (67).
In C. elegans, the use of mitochondrial mutants, the most popular of 
which are mev-1, gas-1, isp-1 and clk-1 has been used to test for effects of 
various interventions on oxidative stress. In addition, the use of free radical 
generating chemicals such as paraquat, juglone and hydrogen peroxide has 
also been popular. In the following section, an overview of the major OS 
mutants will be presented followed by a review of several recent reports which 
seem to suggest that there is no cause and effect relationship between OS 
and aging. 
mev-1 animals have a missense mutation in the cyt-1 gene coding for 
the succinate dehydrogenase cytochrome b large subunit of complex II. The 
animals in this strain are hypersensitive to oxygen, produce excessive 
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amounts of superoxide anions in their mitochondria and have a shortened 
lifespan. In addition, they also have lower superoxide dismutase levels, 
reduced glutathione levels, and higher lactate concentrations (96).
 gas-1 mutants have a mutation in a subunit of mitochondrial complex 
I that is required for oxidative phosphorylation. Because of this, they have a 
strongly reduced complex I dependent metabolism and an increased 
metabolism of complex II. The mitochondria of these animals appear normal. 
isp-1 is an iron sulphur protein that is a subunit of the mitochondrial complex III 
in the mitochondrial membrane. Complex III catalyzes electron transport from 
ubiquinol to cytochrome c. 
The isp-1 mutants show reduced oxygen consumption and decreased 
sensitivity to ROS. These mutants are long lived. Because the ISP-1 mutation 
affects the rate of development and production, the isp-1;ctb-1 double mutant 
is often used to ensure that the slow embryonic development is not a 
confounding factor. The CTB-1 gene encodes the cytochrome b protein of 
mitochondrial complex III. As stated above, it rescues the abnormal 
development of isp-1 mutants and also increases their resistance to paraquat. 
Another gene that is involved with regulating mitochondrial respiration 
in C. elegans is CLK-1. This gene is required for biosynthesis of Coenzyme Q 
(Ubiquinone), which reduces the amount of superoxide anion in the 
mitochondrial respiratory chain. CLK-1 codes for a highly conserved 
demethoxyubiquinone (DMQ) hydroxylase that is necessary for normal 
physiological rates of growth, development, behavior, and aging, and normal 
brood sizes (80). clk-1 mutants have an increased resistance to oxidative 
stress. The metabolic activity and ATP levels of clk-1 mutants are unchanged. 
Clk-1 mutants have an extended lifespan.
33
1.9.4.1 Knockout models 
Besides the use of mutant and/or double or triple mutant animals, 
several strategies have been employed to examine the relationship of 
oxidative stress and aging in C. elegans. The most popular of these has been 
to knock out the antioxidant enzymes that are responsible for the endogenous 
oxidative stress response. The idea behind these experiments is that deleting 
some or all of these enzymes will increase oxidative stress. If the free radical 
theory of aging is correct, this increase of oxidative stress should be followed 
by a decrease in lifespan. Interestingly, it was recently shown that this is not 
the case. Two groups systematically knocked out every one of five superoxide 
dismutases in the worm and showed that there was either no change, or 
sometimes even an increase in lifespan. This suggests that in C. elegans, 
oxidative stress is not causal for aging. However, damage from ROS in 
conjunction with damage from other sources still likely contributes to aging 
(66,67). Moreover, a study published by Schulz et al. has shown that oxidative 
stress can in some cases actually increase lifespan. These researchers 
showed that when C. elegans were put on a glucose-restricted diet, they had 
increased mitochondrial respiration and higher production of ROS, yet still 
lived longer than the controls. They hypothesized that the observed increase 
in lifespan was due to hormesis within the mitochondria, which they termed 
“mitohormesis.” Interestingly, when antioxidant treatments were applied to 
animals on a glucose-restricted diet, lifespan actually decreased (97). This 
seems to counter one of the fundamental tenets of the free radical theory of 
aging, that ROS causes damage and decreases lifespan, and antioxidants 
rescue this effect.  
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It is important to note that while at present there is much contention 
regarding the validity of the free radical theory, it still provides a powerful 
explanation for aging-related states, which implicate ROS damage as the main 
culprit. Alzheimer’s disease is one such example. Additionally, the free radical 
theory of aging has been incorporated into other, new theories such as the 
green theory of aging (69).
1.10 Calorie restriction and other mutants 
Calorie restriction (CR) is the only known intervention that has been 
shown to increase lifespan in organisms ranging from yeast to primates. In C. 
elegans, CR can be achieved on one of three ways: dilution of the bacterial 
source, culture in semi-defined liquid medium in the absence of E. coli or 
through the use of mutants. The first reported case of calorie restriction in C. 
elegans was done by diluting the concentration of E. coli is S medium. Upon 
treatment, worm lifespan increased and fertility decreased (98). Similarly, 
Hosono et al. decreased food intake by reducing the thickness of the bacterial 
lawn on solid agar plates. This was accomplished by reducing the nutrient 
content of these plates (99). 
The third way by which calorie restriction of C. elegans can be achieved 
is through the use of mutants. The major example of this is the eat-2 mutant 
strain, which has a pump rate that is naturally lower than wild-type. This strain 
has a mutation in the ligand-gated ion channel subunit of the pharynx, which 
causes the worm to pump at a much slower rate than normal and therefore 
take in less food per unit time. The EAT-2 gene is required for normal life span 
and defecation. As expected, animals that have a mutation in eat-2 are longer 
lived compared to wild-type. 
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Another pathway, which is implicated in extending lifespan via CR is 
TOR (target of rapamycin). Mutants of this pathway have been suggested to 
modulate life extension by CR (100). TOR is a conserved protein kinase that 
plays an essential role in regulating growth and metabolism in response to 
nutrients and growth factors. TOR interacts with the regulatory associated 
protein of TOR (raptor) to allow transduction of nutrient signals to a wide range 
of downstream cellular processes, such as mRNA translation, ribosome 
synthesis, expression of metabolism-related genes and autophagy. One of the 
major functions of TOR is to promote protein synthesis by activating S6K and 
inhibiting eukaryotic translation initiation factor 4E-binding protein (4E-BP). 
Modulation of mRNA translation plays an important role in lifespan 
determination in many species. In C. elegans, mutations in the TOR ortholog 
let-363 leads to developmental arrest at dauer (third larval stage) and 
intestinal atrophy. The arrest at the third larval stage is also observed with 
homozygous but not heterozygous mutants of daf-15, the C. elegans ortholog 
of raptor. Heterozyous mutants of raptor have an increased lifespan. 
Additionally, inactivation of rsks-1, the C. elegans ortholog of S6K extends 
lifespan. S6K is phosphorylated by Akt/PKB, suggesting that there is crosstalk 
between the IIS and TOR pathways (101). RNAi of let-353 extends lifespan of 
wild-type animals, but not of pep-2 mutant animals. PEP-2 is a proton-
dependent carrier, which regulates the uptake of di- and tripeptides. Evidence 
suggests that pep-2 acts upstream of TOR through PI3K and AKT (100). Major 
questions about the role of TOR in CR-mediated life extension still remain. It is 
still uncertain for example whether inhibiting let-363 by RNAi further extends 
lifespan of the eat-2 mutant (102).  
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1.11 Pharmacological manipulation of aging  
C. elegans is a good model for aging research because as they grow 
older, worms experience a variety of behavioral and physiological declines 
similar to higher mammals, including humans (77, 98). As they age, worms 
move more slowly and exhibit sarcopenia - the progressive deterioration of 
muscle tissue. They also become infertile, and accumulate oxidized proteins 
and lipofuscin, both of which are hallmarks of aging in most species (77, 98). 
At the gene and protein levels, C. elegans share a number of homologs with 
human genes and a conserved protein network involved in aging (103, 104). 
Besides being a biologically relevant aging model, worms are easy to culture 
and have a short life cycle, allowing for rapid replication of experimental 
treatments.
In C. elegans, standard assay conditions to study the 
pharmacology of drugs and interactions with genes have been described 
(105). To date, a variety of human pharmacological interventions ranging from 
vitamins and individual phytochemicals to clinical drugs and antioxidant 
supplements are known to extend lifespan or delay physiological aging in C. 
elegans (61, 106). Recently, whole-plant phytochemical extracts have also 
been tested and found to have a significant life-extending effect (107-109). 
Some of these studies are reviewed below. However, before proceeding, I feel 
that it is important to point out some caveats that make the interpretation of 
this information less than ideal.  
While pharmacological manipulation of aging is an exciting and 
important area of research because it has the potential to alleviate age-related 
pathologies, a number of factors must be noted when analyzing data and 
trying to compare different studies. First, background of the control strain such 
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as N2 vs. the sterile fem-1 must be noted when comparing studies. A number 
of reports have been published using same or similar compounds, yet different 
control strains making it harder to draw direct comparisons (94, 110, 111). 
Second, temperature at which the experiment is performed plays a major role. 
Since temperature has a direct effect on lifespan in C. elegans, there usually 
exists an optimal temperature at which the maximum effect of a 
pharmacological treatment is observed. Thus if an experiment is only done at 
one temperature and no effect is observed, this result may be due to 
pleiotropy, or masking of the effect(s) between temperature and compound(s) 
of interest. However, a number of groups have taken this into account and 
performed pharmacological lifespan analyses under a range of different 
temperatures to show that the effects are robust and reproducible at a range 
of temperatures. Thirdly, the E. coli bacteria source plays a vital role. Usually, 
the uracil-requiring OP50 strain is used as the food source. Because bacteria 
can metabolize drugs, it is important to ensure that the effect is not due to the 
bacteria, but rather due to the drug acting directly on the worm. This caveat 
can be overcome by killing the bacteria. A variety of methods exist to do this, 
the most popular of which are UV irradiation and addition of antibiotic to which 
the bacteria is sensitive. However, most reports that have been published to 
date have only reported results on live bacteria. Thus, the possibility exists 
that the effects are due at least in part to bacterial metabolism rather than 
direct drug action on the worms. Fourthly, some compounds only exert their 
effects when administered at hatching, while others need to be administered 
at sexual maturity to avoid deleterious developmental effects. Many studies 
only publish one or the other, but not both. Sometimes it is difficult to tell at 
what stage the treatment began altogether. Fifth, it is important to know if the 
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compound affects the number of progeny of the animals. Many compounds 
that extend lifespan show reproductive toxicity, reduced metabolism and 
reduced respiration. Sixth, it is possible that the compound may be toxic 
without exerting a phenotypic effect by inducing caloric restriction. 
Traditionally, the pump rate is measured to ascertain whether worms are 
feeding normally. Seventh, a lot of compounds must be dissolved in a vehicle 
solvent that is not evaporated off by the end of its preparation. Therefore, the 
appropriate controls must include the solvent at the same percentages as the 
treatment groups. Moreover, lifespan assays are usually done on NGM petri 
plates and the pharmacological extract of interest must be dissolved at no less 
than 55°C (to ensure that the agar does not solidify), along with the NGM 
media, this can raise issues of stability of the pharmacological agent as this 
high of a temperature may disrupt its structure. Eighth, some compounds such 
as Vitamin E are light sensitive and degrade quickly upon contact with light. 
Four of the papers that are reviewed below used this vitamin to show an affect 
on lifespan (or lack thereof). However, not a single paper reported whether 
they covered the experimental petri dishes. This may mean that none of them 
did, but given that it is a well-known fact that Vitamin E is unstable, it would be 
useful to know the details of the experimental setup. Perhaps the lack of this 
information may also explain some of the observed differences between these 
researchers. If they plates had been covered, careful attention must be paid 
so as not to induce hypoxia to which C. elegans are extremely sensitive. 
Finally, a nice review by Gems and Partridge summarizes a list of important 
caveats to keep in mind when doing experiments using mutant strains to test 
for drug interactions (112).
To date, close to 30 reports on the pharmacological manipulation of 
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aging in C. elegans have been published. More often than not, at least some 
of these caveats are not addressed in these reports. Lack of standardization 
may make it difficult to compare studies and halt the pace of progress. These 
caveats not withstanding, C. elegans remains one of the best models to study 
aging. For the ease of this review, studies will be grouped into four categories: 
vitamins, antioxidants, drugs and natural products.   
1.11.1 Effect of vitamins
In 1983, Zuckerman and Geist published the first report of an 
intervention to extend lifespan in C. elegans (113). These researchers showed 
that Vitamin E (d,1-α-tocopherol) at a dose of 200 µg/mL can increase both 
the mean and the maximum lifespan of C. elegans if treatment is started 
during the prereproductive period. In a subsequent publication, Harrington and 
Harley confirmed these findings and also found that Viatmin C (L-ascorbic 
acid) or a Vitamin E (d,1-α-tocopherol) and C combination had no effect on 
lifespan. In addition, these researchers found that Vitamin E decreased 
fecundity and increased the mean day of reproduction (110). Vitamin E 
consists of two major forms, the tocopherols (α-tocopherol, β-tocopherol, δ-
tocopherol and γ-tocopherol), and the tocotrienols (α-tocotrienol, β-tocotrienol, 
δ-tocotrienol and γ-tocotrienol). The tocopherols, in particular α-tocopherol is 
the predominant form absorbed by the human body and found in tissues of 
most animals. The major difference between these two forms is three double 
bonds (e.g. lack of saturation of the isoprenoid tail) found in the tail of 
tocotrienols. However, the antioxidant activity of these two forms varies 
greatly. Although the tocotrienols only have about 1/3 the biological activity of 
tocopherols, they have 40-60% more antioxidant activity. Adachi and Ishii 
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found that a tocotrienol fraction, but not a tocopherol fraction increased the 
mean lifespan in C. elegans. This increase was paralleled by a lowering of 
protein carbonylation and an improved survival upon exposure to UVB 
irradiation, which induces cumulative oxidative stress by generating hydrogen 
peroxide and hydroxyl radicals. Interestingly, the survival was improved when 
the tocotrienol fraction was applied both pre and post – UVB treatment. 
Surprisingly, this report differed from the two previous findings that α-
tocopherol increased lifespan in C. elegans. There may be several 
explanations for this. First, the researchers administered a much lower dose 
than previously reported (highest dose used was 80 µg/mL instead of 200 µg/
mL) since they wanted to use the same dose for both forms of vitamin E and 
they had reason to believe that the 80 µg/mL dose would be more efficient for 
the tocotrienol fraction. Second, they used a tocopherol fraction rather than 
using the α-tocopherol isomer, as did previous reports. Although α-tocopherol 
is the most biologically active form, it may be that combining all four tocopherol 
isomers abrogates α-tocopherol’s activity when assessing for lifespan 
increase and protein oxidation. Thirdly, it was not clear from this study at what 
stage of development treatment with Vitamin E was begun. The two previous 
studies, which reported an effect started treating at hatching, it was not 
immediately clear from the information supplied in the paper whether this was 
also the case here (94). Another study by Zou et al. found that Vitamin E 
extends lifespan in C. elegans even when supplied at young adulthood (111). 
These researchers found that contrary to the two early studies, -tocopherol atα  
the high dose of 200 µg/mL slightly reduced mean lifespan compared to the 
control. In contrast, -tocopherol increased mean lifespan at both 20 and 200γ  
µg/mL. Neither dose affected maximum lifespan, and mixing both forms in 
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equivalent ratios produced no significant effect on lifespan. The researchers 
concluded that -tocopherol supplementation could suppress any benefits ofα  
-tocopherol supplementation in this model. A possible explanation as to whyγ  
these results differed from the two early studies could be that treatment in this 
case was begun post-reproductively. Also, the sterile fem-1 strain was used 
instead of the wild-type N2. Interestingly, in this study a comparative approach 
was used to test the effects of - and α γ- tocopherol on two fly species, D. 
melanogaster and A. ludens. In D. melanogaster, supplementation had no 
effect on males and slightly reduced the mean lifespan of females. In A. 
ludens, there was no effect on both males and females (111).
 
1.11.2 Effect of Drugs
The anti-aging effects of several clinical drugs have been tested in C. 
elegans. Evanson et al. screened 19 FDA approved anticonvulsant drugs and 
found that ethosuximide extended mean lifespan by 17%. In a follow-up study 
of the structure-activity relationship, a group of structurally-related 
anticonvulsants was tested. Of these, it was found that trimethadione 
increased mean lifespan by 47% and DEABL by 31%. These drugs modulate 
neural activity in vertebrates and were found to regulate neuromuscular 
activity in worms. The authors concluded that the anticonvulsant activity of 
these drugs is directly responsible for extending lifespan and therefore that 
neural activity plays a role in the regulation of aging. Two models were 
proposed for how this may occur. In the first model, neurons promote lifespan 
directly by modulating processes that are essential for life. In this model, age-
related decline is delayed by anticonvulsant drugs, which delay neuronal 
degeneration. Alternatively, activity of the neurons contributes to aging by 
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accelerating aging of nonneuronal cells, which promote survival. Here, 
anticonvulsant drugs may function to decrease the levels of neuronal activity. 
The authors concluded that, the second model is better supported by the 
evidence. Specifically, in nematodes treated with these drugs, egg laying was 
increased because eggs were deposited earlier, there was increased motility 
(fast body movement) and hypersensitivity to the acetylcholinestarase inhibitor 
aldicarb was observed. Additionally, the IGF pathway was shown not to be 
required for the actions of the drug. The authors concluded that because 
drugs that affect neural activity delay the aging of nonneronal reproductive 
tissues, model 2 was probably the most likely explanation (114,115).
Similarly, Voisine et al. performed a screen of 16 drugs used to treat 
Huntington’s disease and found that mithramycin and lithium chloride, extend 
lifespan of the pqe-1 mutant in a daf-16 independent manner. The pqe-1 
mutant is a model of Huntington’s disease in which polyQ mediated neuronal 
degeneration and aging are accelerated. By assaying neuronal survival using 
GFP fluorescence and a dye, the researchers showed that these drugs slowed 
the degeneration of neuronal cells (116). Last, but not least, Petraschek and 
colleagues performed a screen of 80,000 compounds and identified a drug 
mianserin used to treat depression in humans that extends maximum lifespan 
by up to 31%. A detailed description of the experiments performed and 
mutants tested is beyond the scope of this review, however, a variety of 
mutants were used to determine that mianserin affects serotonin synthesis, 
serotonin re-uptake at synapses, or either of two G-protein-coupled receptors, 
data which were in agreement with data on humans (117). This study 
combined with the two reviewed above strongly suggest that neuronal activity 
and aging are closely linked. 
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1.11.3 Effect of Antioxidants
Several studies have examined the effects of administering antioxidants 
to C. elegans as a way to extend lifespan. According to the free radical theory 
of aging (reviewed above), free radicals are the main agents of damage to 
DNA, proteins and lipids. These radicals produce byproducts that accumulate 
in the cell over time and lead to cellular senescence and aging. Melov et al. 
have reported using superoxide dismutase and catalase mimetics, EUK-8 and 
EUK-134, respectively, to extend lifespan of C. elegans. These researchers 
found that in liquid culture mean lifespan increased by up to 44%. To address 
the mechanism of action, the researchers showed that the drugs extended the 
lifespan of the mev-1 mutant, a strain with a mutation in the complex II of the 
mitochondrial respiratory chain that is defective in reactive oxygen species 
(ROS) metabolism (reviewed above). It was also found that these drugs did 
not significantly affect growth or fertility (93). In agreement with this result, 
Sampayo and colleagues used the same compounds and found that there 
was a dose-dependent increase in survival of paraquat treated and heat 
shocked animals, further providing proof that these compounds act as 
antioxdants in vivo. In addition, these researchers showed that this effect is 
independent of insulin signaling (106). However, in a follow-up study, Gems 
and colleagues found that the increase in lifespan was not reproducible (and 
showed that it even decreased) calling into question the results of the first 
study as well as the free radical theory of aging. The researchers did however 
find that drug treated animals had elevated levels of superoxide dismutase 
activity. Moreover, they also found that treatment with the drug mimetics 
improved survival animals exposed to oxidative stress, but not those 
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maintained under normal conditions. The authors concluded that antioxidant 
mimetics do not increase lifespan under normal conditions and speculated that 
the discrepancy in the results compared with the previous group was due to 
different culturing conditions (the first group used liquid culture that the authors 
suggested may have generated additional oxidative stress). These studies 
show that for the reasons discussed above, culturing conditions are crucial 
when interpreting lifespan studies (118,119). 
Resistance to stress has been linked to increased longevity (120). A 
recent study by Benedetti et al. tested a wide range of antioxidant compounds 
by utilizing a screen for thermotolerance (121). Candidates that were found to 
improve thermotolerance were further tested for their lifespan effects. Out of a 
total of six compounds, lipoic acid, propyl gallate, trolox and taxifolin were 
found to extend lifespan under normal culturing conditions. Interestingly, while 
there were no deleterious effects on fecundity, the authors found a delay in 
fertility for lipoic acid and a reduction in the size of the progeny of lipoic acid 
and propyl gallate treated animals. To address the mechanism of action, the 
authors used several GFP reporter strains: sod-3, gst-4, hsp16.2 and cyp-
35A3. CYP-35A3::GFP showed a 2-fold increase in expression upon 
treatment with trolox. This gene is regulates the xenobiotic stress response. 
The authors concluded that the xenobiotic stress response may contribute to 
the observed lifespan extension. Alternatively, since heat shocked worms 
show dramatically increased production of ROS it was suggested that these 
compounds can directly detoxify ROS. Perhaps, death from thermal stress 
may be mediated by oxidative stress. 
Several other studies looked at the use of ions and nanoparticles as 
antioxidants on C. elegans lifespan. Kim et al. showed that platinum 
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nanoparticles increased the lifespan of N2 worms, increase survival upon 
paraquat treatment, attenuated ROS by increasing the lifespan of mev-1 
mutants, and decreased levels of lipofuscin (95). Lin and colleagues found 
that manganese ion supplementation enhanced resistance to oxidative stress, 
and rescued the lifespan of mev-1 mutant animals. Interestingly, the authors 
also observed accelerated development of wild-type animals. The authors 
proposed that manganese may act as a free radical scavenger or alternatively 
may regulate other protective factors (122). Vitamin E and its various forms, 
which were reviewed above is also a potent antioxidant. Taken together the 
data in this section show that, while antioxidants may come in many different 
forms, they have a common activity – to alleviate the damage caused by ROS 
and increase lifespan in some, but not all cases. 
1.11.4 Effect of Natural Products
Recently, natural products or compounds derived from them have been 
tested in the lifespan manipulation of C. elegans. These included both single 
compounds as well as plant extracts. The most familiar example from recent 
history is resveratrol, a stilbene found in grapes, peanuts and other plant 
foods. This phytochemical was shown to extend lifespan in C. elegans by 
anywhere between 10-52% (89, 123). This effect was mediated through the 
sir2.1 pathway. For a time, this finding generated a lot of excitement as study 
after study in different model organisms found that this effect on lifespan or 
age-related decline was reproducible (124-126). However, another study 
showed that resveratrol’s effects on the lifespan of both C. elegans and D. 
melanogaster were variable. Whereas in some cases it increased lifespan 
slightly, in others it did not, suggesting that the mechanism of action is more 
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complex than previously thought, and that it is at least in part dependent on 
culturing techniques (127). It is important to note that resveratrol does not act 
solely via sir2.1. In a recent article, Pirola reviewed the many molecular 
targets of this interesting compound, which include the phase II detoxification 
system and AMP kinase (128). Other single phytochemicals, which have been 
shown to extend lifespan, increase stress resistance, or both include 
kaempferol, rutin fistein, quercetin and EGCG. The two latter examples are 
discussed in greater detail in section 2.4.
Three whole plant extracts have been shown to increase lifespan in C. 
elegans. A number of studies using the Ginko biloba extract EGb 761 in C. 
elegans have been published. Ginko biloba has been used medicinally in 
China for thousands of years to enhance memory and prevent dementia. Luo 
et al. showed that amyloid beta aggregation was inhibited in an Alzheimer’s 
disease model of C. elegans (129, 130). In this model, the human gene for 
Aβ42 is overexpressed. The resulting amyloid beta aggregates lead to paralysis 
and death. Interestingly, only aggregates of a certain size cause this effect. 
Kampkotter et al. showed that EGb671 reduces stress sensitivity to ROS, 
expression of catalase and glutathione-S-transferase (131). Wu et al. have 
shown that the Ginko biloba extract EGb 761 increased the mean lifespan of 
wild-type worms by 8%. It was shown that oxidative stress was decreased in 
both the wild-type and mev-1 mutant and that thermotolerance was increased 
following EGb 761 administration in both wild-type and mev-1 animals (107). 
In another study with the same extract, Strayer et al. showed that hsp16.2 
expression was decreased following treatment. This effect correlated with the 
organism’s increased survival upon thermal and oxidative stress. Without 
ruling out other possible effects, the authors concluded that reduced hsp16.2 
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expression led to reduced cellular stress (132). Cao et al. reported that EGb 
761 decreased sarcopenia in a PD4251 model (which expresses GFP in body 
wall muscles and vulval wall nuclei) of C. elegans. The authors also observed 
an improvement in locomotion, body bending and pharyngeal pumping (133). 
Plant adaptogen extracts have also been tested for their lifespan effects 
in C. elegans. Wiegant and colleagues showed that extracts of 
Eleutherococcus senticosus and Rhodiola rosea increased the mean lifespan 
of wild-type animals in a dose-dependent manner between 10-20%. In 
addition, both extracts also increased stress resistance against heat shock 
and oxidative stress and induced translocation of DAF-16 into the nucleus. 
The authors concluded that these adaptogens are experienced by C. elegans 
as mild stressors and thereby act to enhance general stress resistance and 
increase lifespan (109).
The only study to test the effects of whole extract fruit (berry fruits) 
phytochemicals on lifespan was done by Wilson et al. who showed that crude 
blueberry extracts increase lifespan and enhance thermotolerance of C. 
elegans (108). This study found that mean lifespan of fem-1 worms was 
increased by 28%. Unlike in the Ginko biloba study, these authors did not find 
that whole plant extract increased lifespan by relieving oxidative stress 
(although they left open the possibility that low levels of oxidative stress may 
be quenched). The authors tested a variety of longevity mutants. The premise 
of these experiments was that blueberry treatment would not extend lifespan 
in mutant animals missing a gene required for blue berry’s beneficial effect. 
Mutants of various known aging pathways, including daf-16, sir2.1 and eat-2 
were tested. These pathways did not appear to be affected by the extracts. 
However, mutants of the OSR-1/UNC-43/SEK-1 osmotic stress resistance 
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pathway did not show increased lifespan. The authors thus concluded that this 
pathway was necessary for lifespan extension with blueberry extracts. To get 
at the fraction of blueberry extracts, that was responsible for the life-extending 
effect, the extracts were fractionated. It was found that the proanthocyanidin 
(PAC) fraction was responsible for the effect. This is to some extent surprising 
because these compounds are known to have low bioavailability, at least in 
humans. Nonetheless, this study was the first to consider the effects of food, 
and in particular berry fruits on the lifespan and healthspan of C. elegans.
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CHAPTER 2
Apple extracts increase lifespan, healthspan and resistance to stress in 
Caenorhabditis elegans
2.1 Introduction
Natural products derived from plants represent a significant source of 
potential human therapeutic agents. Compounds found in these agents may 
aid in the maintenance of health and the prevention of chronic ailments such 
as cancer, cardiovascular disease, diabetes, Azheimer’s disease, 
hypertension, and cataracts (4). Age is a major risk factor for developing many 
such chronic diseases. As an organism ages, it experiences a progressive 
deterioration of virtually every bodily function over time, resulting in an 
increasing susceptibility to environmental challenge and a growing risk of 
disease and death (59). Therefore, a key goal of aging research is to discover 
compounds that will aid in the prevention and treatment of age-related 
diseases, and delay the onset of aging and age-related morbidity. 
The nonparasitic nematode C. elegans is a popular model in aging 
research because as they grow older, worms experience a variety of 
behavioral and physiological declines similar to higher mammals, including 
humans (77, 98). As they age, worms move more slowly and exhibit 
sarcopenia - the progressive deterioration of muscle tissue. They also become 
infertile, and accumulate oxidized proteins and lipofuscin, both of which are 
hallmarks of aging in most species (77, 98). At the gene and protein levels, C. 
elegans share a number of homologs with human genes and a conserved 
protein network involved in aging (103, 104). Besides being a biologically 
relevant aging model, worms are easy to culture and have a short life cycle, 
allowing for rapid replication of experimental treatments.
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In C. elegans, standard assay conditions to study the pharmacology of 
drugs and interactions with genes have been described (105). To date, a 
variety of human pharmacological interventions ranging from vitamins and 
individual phytochemicals to clinical drugs and antioxidant supplements are 
known to extend lifespan or delay physiological aging in C. elegans (61). 
Recently, whole-plant phytochemical extracts have also been tested and 
found to have a significant life-extending effect (107-109).
Epidemiological studies have consistently shown that regular 
consumption of fruits and vegetables is associated with a reduced risk of 
developing chronic diseases (1-3). Doll and Peto estimated that at least one-
third of all cancers can be prevented by dietary modification (134). We and 
others have proposed that the health benefits of fruits and vegetables arise 
from interactions of complex mixtures of phytochemicals, the bioactive non-
nutrient plant compounds that have been linked to reducing the risk of major 
chronic diseases. These compounds may possess additive and synergistic 
effects and provide benefits beyond those obtained from individual 
supplements (4).
Apples are so commonly consumed in the U.S. that they are the top 
contributor of fruit phenolics in American diets (38). Whole apple extracts had 
potent antioxidant effects and anti-proliferative activity against colon, liver and 
breast cancer cells in vitro in a dose-dependent manner (49, 50, 52, 135). 
They prevented DMBA-induced mammary cancer in rats, inhibited NF Bκ  
activation in human breast cancer MCF-7 cells, induced G1 arrest and 
decreased the expression of Cyclin D1 and Cd4 (11, 52, 54). Recent work at 
our lab also included the isolation of new, structurally diverse compounds from 
apple peels that had potent antioxidant effects and anti-proliferative activity 
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against MCF-7 breast cancer cells and HepG2 liver cancer cells (40, 51). 
Although many such molecular health effects of apple phytochemicals have 
been identified, little is known about their effects on aging. The objective of 
this study was to determine the effects of apple phytochemical extracts on 
lifespan, healthspan and stress resistance in vivo using Caenorhabditis  
elegans as a model for human aging.
2.2 Methods and materials
 2.2.1 Chemicals and reagents
Acetone was purchased from Fischer Scientific (Pittsburgh, PA). 
Sodium carbonate was purchased from Mallinckrodt Baker, Inc. (Phillipsburg, 
NJ) and gallic acid from ICN Biomedical Inc. (Aurora, OH). Folin-Ciocalteu 
reagent, 5-fluoro-2-deoxyuridine (FUDR) and methyl viologen dichloride 
hydrate (paraquat) were purchased from Sigma-Aldrich (St. Louis, MO). 
2.2.2 Extraction of apples
Fresh apples of the Red Delicious variety were purchased from Cornell 
Orchards (Cornell University, Ithaca, NY) and extracted using the method 
previously reported by our laboratory (50). Briefly, whole apples were sliced, 
blended in ice-chilled 80% acetone, homogenized and rotary evaporated 
under vacuum at 45°C until approximately 90% of the filtrate (and all acetone) 
had been evaporated. The concentrate was re-suspended in water, and no 
other solvent remained in the extract. Apple phytochemical extracts were 
frozen at –80oC until use.  The extracts have been characterized based on 
bioactivity-guided fractionation and structure identification using HR-MS, 1D 
and 2D NMR, and X-ray diffraction analysis using the method we reported 
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previously (40).
2.2.3 Determination of total phenolic content
Total phenolic content of apples was measured using a modi edﬁ  
colorimetric Folin-Ciocalteu method (136). Briefly, volumes of 0.5 mL of 
deionized water and 0.125 mL of apple extracts diluted 1:10 in triplicate were 
added to test tubes. Folin-Ciocalteu reagent 0.125 mL) was added to the 
solution and allowed to react for 6 min. Next, 1.25 mL of 7% sodium carbonate 
solution was aliquoted into the test tubes, after which deionized water was 
added to adjust the mixture to 3 mL. The color was developed for 90 min, and 
the absorbance was read at 760 nm using a MRX II Dynex spectrophotometer 
(Dynex Technologies, Inc., Chantilly, VA). Absorbance values were compared 
to a standard curve of known gallic acid concentrations and expressed as 
milligrams of gallic acid equivalents (GAE) per 100 g of fresh fruit ± SD for 
triplicate extract samples.
2.2.4 Strains, maintenance and culturing of nematodes
Strains used were: Bristol N2 (wild-type), daf-16(mgDf47) and age-
1(hx546). All strains were generously shared by the lab of Dr. S.S. Lee 
(Cornell University, Ithaca, NY). Animals were maintained at 20ºC on petri 
dishes containing Nematode Growth Medium (NGM) seeded with a live E. coli 
strain OP50 as the food source according to the general procedures outlined 
by Brenner (137). 
2.2.5 Lifespan assay
Several gravid adult nematodes were placed on NGM plates seeded with 
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E. coli strain OP50 and allowed to lay eggs at 20ºC for approximately 6 hours 
to obtain a synchronous population. After 6 hours, the nematodes were 
removed and the plates were placed back at 20ºC until the progeny reached 
young adulthood (about 72 hours). On day 0 of the experiment, these young 
adult nematodes were transferred to 35 mm NGM petri dishes containing 
either no apple extracts or the appropriate doses of dissolved apple extracts 
and 50 µM of 5-fluoro-2-deoxyuridine (FUDR) to prevent progeny production. 
Plates were then dried in a sterile hood, seeded with 100 µL of 3-fold 
concentrated, saturated E. coli OP50 culture, and dried again. Animals were 
transferred every other day to fresh extracts or control plates until day 8 of 
adulthood. Worms were scored daily or every other day by gentle prodding 
with a platinum wire. Those animals that failed to move were scored as dead. 
Animals, which exhibited bagging, exploded or crawled off the plates, were 
censored. Statistical analyses were performed using SPSS statistical software 
Kaplan-Meier Survival function; p-values were obtained using the log-rank 
test. The experiment was repeated multiple times and a representative trial is 
shown. All experiments, except for the P. aeruginosa pathogen killing assay 
and heat shock treatment were performed at 20ºC. 
2.2.6 Healthspan assays
2.2.6.1 Lipofuscin
Animals (N=18 per group) were treated as per the lifespan assay 
described above, picked off the plates on day 8 of adulthood, placed onto 2% 
agarose pads and immobilized in 20 µM sodium azide (108). Slides were 
visualized using the Leica DM5000B Microscope (Bannockburn, IL), with the 
I3 cube filter (excitation 450/490, emission 510), and images were captured 
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using a Hamamatsu ORCA-ER camera and OpenLab software. Image 
quantification of fluorescence intensity was done densitometrically by tracing 
around each animal’s intestine and determining average pixel intensity using 
imageJ freeware (NIH) (135). 
2.2.6.2 Motility assay 
The effect of apple extracts on motility of the worms was determined by 
a motility assay adapted from Herndon et al. and Golden et al. (81, 138). 
Animals were treated as per the lifespan assay described above. On days 12, 
14, 16 and 18 of adulthood, animals were visualized using an Olympus SZ61 
stereomicroscope (New York/New Jersey Scientific, Middlebush, NJ). Motility 
classes were determined using the method reported by Golden et al., where 
'A' worms move spontaneously and smoothly, leaving sinusoidal and 
symmetric tracks;  'C' worms only move the nose or tail when prodded with a 
platinum wire; and 'B' animals represent every behavioral class in-between. 
N≥47 animals for days 10 and 12, N≥25 for day 16. 
2.2.7 Stress resistance assays
For all stress resistance assays, animals were transferred to 35 mm 
NGM/OP50 plates with apple extracts or control plates at the young adult 
stage containing 50 µM FUDR, then incubated for two days followed by 
exposure to the stressor on the third day of adulthood. All trials were repeated 
at least 2-3 independent times, and a representative trial is shown. 
2.2.7.1 Heat shock
Animals were incubated at 35ºC on the third day of adulthood for 8 
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hours and monitored every 30 minutes thereafter until approximately 50% of 
the controls had died. Plates were pulled out of the incubator and scored for 
survival (139). Triplicate plates were used per each time point with N 61≥  
animals per group. 
2.2.7.2 UV irradiation 
Animals were transferred to bacteria-free NGM plates on day three of 
adulthood and UV-irradiated at 1200 J/m2 with a UV Stratalinker 2400 
(Stratagene, La Jolla, CA) equipped with five 254 nm UV light bulbs (model 
1800), each generating 15 watts. After UV irradiation, animals were 
transferred back to the standard NGM/OP50 plates without apple extracts and 
monitored daily for survival by gentle prodding with a platinum wire (140). 
N=66, 82, 79, 72 animals for 0, 2.5, 5 and 10 mg/mL groups, respectively. 
2.2.7.3 Pseudomonas aeruginosa infection
Animals were grown on NGM/OP50 plates at 25ºC and transferred to 
plates with or without apple extracts for a period of two days. On the third day 
of adulthood, animals were shifted to modified NGM plates containing P. 
aeruginosa strain PA14 at 25ºC, and scored for survival every 8-13 hours. 
These modified NGM plates were prepared according to the method of Tan et 
al. (141). Briefly, plates were seeded with 10 µL of P. aeruginosa, allowed to 
dry overnight at 37ºC and then at room temperature for another 24 hours. 
N=82, 80, 73 and 76 animals for 0, 2.5, 5 and 10 mg/mL groups, respectively. 
2.2.7.4 Oxidative stress 
The oxidative stress paraquat assay on plates was performed using the 
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methods described previously (96, 123). On day three of adulthood, animals 
were transferred to freshly prepared NGM/OP50 plates, containing 10 mM 
paraquat and scored as above. N≥54 animals per each group. 
2.2.8 Brood size 
 N2 worms were grown on NGM/OP50 plates until the late L4 stage and 
transferred to the control plate or plates with different concentrations of apple 
extracts, one worm per plate per concentration, with N=8 animals per group. 
Animals were then transferred every 24 hours to the fresh control or apple 
extracts plates until egg production had ceased. Total number of progeny that 
grew up from each worm was counted, and the number of progeny for each 
concentration was averaged (142). 
2.2.9 Statistical analyses 
Survival data were analyzed using SPSS version 16 for Windows 
(SPSS Inc., Chicago, IL) Kaplan-Meier Survival function and log-rank test. All 
other analyses were done using Minitab statistical software (State College, 
PA). Data for heat shock were analyzed using two-sample t-test (assuming 
equal variance); lipofuscin accumulation and brood size were analyzed using 
one-way ANOVA; motility classes were compared using logistic regression. 
Graphs were plotted with the SigmaPlot version 10 for Windows software 
(Systat Software Inc., San Jose, CA). A p- value < 0.05 was considered to be 
statistically significant. 
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2.3 Results
2.3.1 Effect of apple extracts on wild-type C. elegans lifespan
Wild-type adult C. elegans have an average lifespan of 2-3 weeks at 
20ºC. Under our standard laboratory conditions, control wild-type animals lived 
an average of 17.23 ± .30 days (maximum of 24 days). After administering 2.5, 
5 and 10 mg/mL of apple extracts under standard laboratory conditions, 
starting at the young adult stage, mean lifespan increased to 20.46 ± .17 days 
(maximum of 24 days), 21.38 ± .35 days (maximum of 30 days) and 24.05 ± .
53 days (maximum of 30 days), respectively, in a significant, dose-dependent 
manner (Figure 2.1; Table 2.1). These changes represent lifespan increases 
of 18.7, 24.1, and 39.6 %, respectively, when compared to the control group 
(Figure 2.2; Table 2.1). 
2.3.2 Effect of apple extracts on motility and lipofuscin accumulation 
Next, we examined whether the increase in lifespan was accompanied 
by an overall improvement in health and vitality. To this end, we tested the 
motility of 12-, 14-, and 16-day-old worms treated with three concentrations of 
apple extracts. Motility was classified according to movement spontaneity on 
petri dishes: Class A animals moved spontaneously; class B animals required 
prodding to stimulate whole-body movement; and class C animals moved only 
their heads in response to prodding (81, 138). The decline in motility on days 
12, 14, and 16 was delayed significantly in a dose-dependent manner in 
worms treated with low (2.5 mg/mL), moderate (5 mg/mL), and high (10 
mg/mL) concentrations of apple extracts (Figures 2.3-2.5). On day 12, most of 
the animals in all groups continued to move spontaneously, but there was 
already a small, significant difference in spontaneous (Class A) motility among 
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the control and treatment groups (Figure 2.3). By day 14, animals treated with 
low, moderate, and high doses of apple extracts had significantly (p<0.05) 
more high-motility (class A) individuals (63, 49, and 77%, respectively) than 
the control group (15%) (Figure 2.4). By day 16, the dose-dependent effects 
on motility were fully evident (Figure 2.5), such that 92% of the control group 
would barely move their heads with prodding (class C), while 49% of the high-
dose treatment group still moved spontaneously (class A). We continued to 
follow the animals to day 18, when most of the control animals had died, 
treatment groups still displayed highly significant dose-dependent differences 
in motility (data not shown). 
  Lipofuscin is a byproduct of lysosomal degradation that accumulates 
with age in many organisms, including C. elegans (143). Wild-type N2 worms 
treated with 2.5 and 5 mg/mL apple extracts accumulated only about half as 
much lipofuscin as the N2 control worms (Figure 2.6). daf-16 nematodes, 
which age and accumulate lipofuscin at a faster rate than wild-type N2 worms, 
were used as a positive control. As expected, they accumulated more 
lipofuscin after 8 days than did control animals of N2. 
2.3.3 Effects of apple extracts on resistance to heat stress, UV irradiation 
and pathogenic infection
Increased lifespan often correlates with increased stress resistance 
(120, 144). We treated young adult C. elegans with doses of 0, 2.5, 5 and 10 
mg/mL apple extracts for two days, and examined their response to a variety 
of chemical and environmental stressors, including heat shock, UV radiation, 
and the pathogen Pseudomonas aeruginosa. 
Animals were placed in a 35ºC heat shock chamber and monitored until 
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approximately half (55%) of the wild-type N2 controls had died (10.5 hours). At 
that time, 71.4, 87.1 and 89.73% of 2.5, 5 and 10 mg/mL apple-treated 
animals were still alive, respectively. age-1 worms, which are more resistant to 
heat stress, were used as a negative control and survived at a 96.13% rate; 
daf-16 worms, which are more sensitive to heat stress, were used as a 
positive control and had a 28.96% survival rate (Figure 2.7)
In an analogous experiment, N2 worms pretreated with apple extracts 
survived significantly longer after UV irradiation than N2 control worms (Figure 
2.8; Table 2.2). Post-irradiation survival time for N2 worms pretreated with 2.5, 
5 and 10 mg/mL apple extracts was increased by 22.6, 46.2, 61.5%, 
respectively. age-1 worms, which are more resistant to UV stress than N2, 
were used as a negative control and survived 74.4% longer than the N2 
controls. daf-16 worms, which are more sensitive to UV stress than N2, were 
used as a positive control and survived 12.8% less than the N2 controls.
N2 worms treated with apple extracts showed increased resistance to 
the pathogen Pseudomonas aeruginosa.  After being transferred to pathogen-
seeded plates on the third day of adulthood and monitored every 8-13 hours, 
control worms survived an average of 82 ± 2.6 hours, while worms treated with 
2.5, 5 and 10 mg/mL of apple extracts had significantly increased mean 
lifespans of 100 ± 3.8, 111 ± 4.4 and 102 ± 4.4 hours, respectively (Figure 2.9; 
Table 2.3).
2.3.4. Effects of apple extracts on resistance to oxidative stress induced 
by paraquat
To test the antioxidant effects of apple extracts, we placed worms on 
NGM plates containing 10 mM of the superoxide-generating chemical 
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paraquat. While control worms survived 4.97 ± 0.19 days (maximum of 7 
days), worms treated with 2.5, 5 and 10 mg/mL of apple extracts survived for 
7.71 ± 0.32 (maximum of 10 days), 9.41 ± 0.43 (maximum of 14 days) and 
8.54 ± 0.39 days (maximum of 15 days), respectively. These represented 
statistically significant increases in mean life span of 55.1, 89.3 and 71.8% 
over the control (Figure 2.10; Table 2.4). 
2.3.5 Effect of apple extracts on brood size 
To see if apple extracts adversely affected fecundity, brood sizes were 
measured for 8 N2 worms per each group: 0 mg/mL (control), 2.5, 5 and 10 
mg/mL. There were no significant differences between treatment groups and 
the control (Figure 2.11).
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Table 2.1 Effects of apple extracts on mean lifespan of C. elegans.
Treatment N Mean Lifespan*(days) ∆**
p- 
value 
vs. 
control
% of 
Control
0 mg/mL 
(control)
120 17.23±.30 a N.A. 100.0
2.5 mg/mL 132 20.46±.17 b <0.001 118.7
5 mg/mL 158 21.38±.35 c <0.001 124.1
10 mg/mL 120 24.05±.53 d <0.001 139.6
* Mean ± SEM based upon Kaplan-Meier estimator
** Values with no letters in common within each column are significantly 
different; a p-value of < 0.05 was considered to be statistically significant 
based on chi-squared log-rank test).
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Table 2.2 Effect of pretreatment with apple extracts on resistance to UV 
irradiation in C. elegans.
Treatment N Mean Lifespan*(days) ∆**
p-value 
vs. 
control
% of 
Control
0 mg/mL 
(control) 66 3.92±.15 a N.A. 100.0
2.5 mg/mL 82 4.88±.18 b <0.001 122.6
5 mg/mL 79 5.70±.18 c <0.001 146.2
10 mg/mL 72 6.37±.18 c,d <0.001 161.5
age-1 (neg 
control) 36 6.89±.32 d <0.001 174.4
daf-16 (pos 
cont) 38 3.49±.19 e <0.001 87.2
* Mean ± SEM based upon Kaplan-Meier estimator
** Values with no letters in common within each column are significantly 
different; a p-value of < 0.05 was considered to be statistically significant 
based on chi-squared log-rank test).
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Table 2.3 Effect of pretreatment with apple extracts on resistance to infection 
by Pseudomonas aeruginosa in C. elegans.
Treatment N Mean Lifespan* (hours) ∆**
p-
value 
vs. 
control
% of Control
0 mg/mL 
(control) 82 82.0±2.62
a N.A. 100.0
2.5 mg/mL 80 100.0±3.75 b <0.001 122.0
5 mg/mL 73 110.9±4.41 c <0.001 135.2
10 mg/mL 76 102.1±4.4 b,c <0.001 124.5
* Mean ± SEM based upon Kaplan-Meier estimator
** Values with no letters in common within each column are significantly 
different; a p-value of < 0.05 was considered to be statistically significant 
based on chi-squared log-rank test).
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Table 2.4 Effect of pretreatment with apple extracts on resistance to chronic 
challenge with paraquat in C. elegans. 
Treatment N Mean Lifespan*(days) ∆**
p-value 
vs. 
control
% of 
Control
0 mg/mL 
(control) 67 4.97±.19 a N.A. 100.0
2.5 mg/mL 58 7.71±.32 b <0.001 155.13
5 mg/mL 54 9.41±.43 c <0.001 189.3
10 mg/mL 61 8.54±.39 c <0.001 171.83
* Mean ± SEM based upon Kaplan-Meier estimator
** Values with no letters in common within each column are significantly 
different; a p-value of < 0.05 was considered to be statistically significant 
based on chi-squared log-rank test).
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Figure 2.1 Effect of apple extracts on the lifespan of C. elegans. Day 1 young 
adult wild-type animals (N 120 in each group) were treated without (0 mg/mL)≥  
or with a low (2.5 mg/mL), moderate (5 mg/mL) and high (10 mg/mL) dose of 
standardized apple extracts, which contained 170 ± 4.6 mg of phenolics per 
100 g of apples. Survival was monitored starting on day 1 of adulthood. 
Nematodes, that were exposed to three levels of apple extracts survived 
significantly longer than those that did not (p<0.001 for 0 mg/mL compared to 
each treatment group; log-rank test; see Table 2.1) The experiment was 
repeated multiple times and a representative trial is shown.
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Figure 2.2 Effect of apple extracts on the mean lifespan of C. elegans. Bars 
with no letters in common represent groups that are significantly different (see 
Table 2.1).  
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Figure 2.3 Effect of apple extracts on motility of C. elegans treated on day 12. 
Motility was classified into two groups: Motion A animals moved 
spontaneously; Motion B animals required prodding to stimulate movement. 
The decline in motility on day 12 was significantly delayed in a dose-
dependent manner in worms treated with 2.5, 5, and 10 mg/mL of apple 
extract (N  47 animals per group; ≥ binary logistic regression; p=0.001; 
likelihood ratio test statistic G=12.051 with df1). A p-value of < 0.05 was 
considered to be statistically significant. 
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Figure 2.4 Effect of apple extracts on motility of C. elegans treated on day 14. 
Motility was classified into three groups: Motion A animals moved 
spontaneously; Motion B animals required prodding to stimulate movement; 
and Motion C animals only moved their heads in response to prodding. The 
decline in motility on day 14 was significantly delayed in a dose-dependent 
manner in worms treated with 2.5, 5, and 10 mg/mL of apple extract (N  47≥  
animals per group; nominal logistic regression, with two slope parameters; 
p=0.001; likelihood ratio test statistic G=39.1 with df2). A p-value of < 0.05 was 
considered to be statistically significant. 
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Figure 2.5 Effect of apple extracts on motility of C. elegans treated on day 16. 
Motility was classified into three groups: Motion A animals moved 
spontaneously; Motion B animals required prodding to stimulate movement; 
and Motion C animals only moved their heads in response to prodding. The 
decline in motility on day 16 was significantly delayed in a dose-dependent 
manner in worms treated with 2.5, 5, and 10 mg/mL of apple extract (N  25≥  
animals per group; nominal logistic regression, with two slope parameters; 
p=0.001; likelihood ratio test statistic G=84.3 with df2). A p-value of < 0.05 was 
considered to be statistically significant. 
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Figure 2.6 Effect of apple extracts on lipofuscin accumulation in C. elegans. 
Wild-type N2 worms treated with 2.5 and 5 mg/mL apple extracts accumulated 
only about half as much lipofuscin as the N2 control worms (p<0.001 for 0 vs. 
all other groups; One-way ANOVA, Tukey’s multiple comparison test for 
differences among groups; see Appendix II). A p-value of < 0.05 was 
considered to be statistically significant. daf-16 nematodes without extract 
treatment, which age at a faster rate, were used as a positive control. Bars 
with no letters in common are significantly different. N=18 animals per group. 
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Figure 2.7 Effect of pretreatment with apple extracts on resistance to heat 
shock in C. elegans. Animals were treated with various concentrations of 
apple extracts (0, 2.5, 5, or 10 mg/mL, in each group) as young adults for 2 
days at 20°C and exposed to a variety of stressors on the third day of 
adulthood. Nematodes, that were pretreated with apple extracts, survived 
significantly longer after 35°C heat shock. Bars with no letters in common are 
significantly different. N  61 animals per group. Significance was determined≥  
using One-way ANOVA, Tukey’s multiple comparison test for differences 
among groups; see Appendix II. A p-value of < 0.05 was considered to be 
statistically significant).
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Figure 2.8 Effect of pretreatment with apple extracts on resistance to UV-
irradiation in C. elegans. Animals were treated with various concentrations of 
apple extracts (0, 2.5, 5, or 10 mg/mL, in each group) as young adults for 2 
days at 20°C and exposed to a variety of stressors on the third day of 
adulthood. Nematodes, that were pretreated with apple extracts, survived 
significantly longer after UV irradiation at 1200 J/m2. N  66 animals per group.≥  
Animals that were exposed to three levels of apple extracts survived 
significantly longer than those that did not (p<0.001 for 0 mg/mL control versus 
each of the treatment groups; log-rank test; see Table 2.2). A p-value < 0.05 
was considered to be significantly different. The experiment was repeated 
multiple times and a representative trial is shown.
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Figure 2.9 Effect of pretreatment with apple extracts on resistance to 
pathogenic infection in C. elegans. Animals were treated with various 
concentrations of apple extracts (0, 2.5, 5, or 10 mg/mL, in each group) as 
young adults for 2 days at 20°C and infected with P. aeruginosa on the third 
day of adulthood. Animals, that were pretreated with three levels of apple 
extracts survived significantly longer after infection (N  73 animals per group,≥  
p<0.001 control versus each treatment group, log-rank test; see Table 2.3). A 
p-value < 0.05 was considered to be significantly different. The experiment 
was repeated multiple times and a representative trial is shown.
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Figure 2.10 Effect of pretreatment with apple extracts on resistance to 
paraquat-induced oxidative stress in C. elegans. Animals were treated with 
various concentrations of apple extracts (0, 2.5, 5, or 10 mg/mL, in each 
group) as young adults for 2 days and transferred to NGM plates containing 
10mM paraquat on the third day of adulthood. Animals, that were pretreated 
with three levels of apple extracts survived significantly longer (N  73 animals≥  
per group, p<0.001 control versus each treatment group, log-rank test; see 
Table 2.4). A p-value < 0.05 was considered to be significantly different. The 
experiment was repeated multiple times and a representative trial is shown.
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Figure 2.11 Effect of apple extracts on brood size of C. elegans. N=8 animals 
per group. There were no significant differences in total progeny output 
between animals that were treated with or without apple extracts (p=.321, 
One-way ANOVA). A p-value < 0.05 was considered to be significantly 
different.
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2.4 Discussion 
Multiple studies have shown that compounds and extracts derived from 
plants, and in particular plant foods, possess a wide range of health benefits 
including chemoprevention, anti-oxidation, anti-proliferation and modulation of 
a variety of enzymes and transcription factors (4). However, until fairly recently 
direct anti-aging effects of these compounds and extracts had not been 
observed. Kitani et al. showed that green tea polyphenols can increase the 
lifespan of mice by up to 72.6%, and suggested that dietary approaches to 
increasing lifespan, especially those that possess antioxidant effects, warrant 
further investigation (145). Casadesus and colleagues found that a diet 
supplemented with blueberries improved spatial memory and increased 
parameters associated with hippocampal neuronal plasticity (34). Similarly, 
Joseph et al. proposed that berry fruits could slow brain aging by lowering 
oxidative stress and inflammation, modulating cell signaling involved in 
neuronal communication and neuroprotective stress shock proteins, and 
buffering calcium levels (33). In C. elegans, Wilson et al. showed that 
supplementation of the nematode diet with blueberry extracts extends lifespan 
via the CaMKII pathway and improves thermotolerance (108). Perhaps the 
most familiar example of a plant-derived compound with anti-aging properties 
from recent history is resveratrol, a phytochemical found in the skins of 
grapes, red wine, peanuts and other plant foods. Resveratrol has been shown 
to increase lifespan under certain conditions in multiple species via 
mechanisms that may involve a wide spectrum of targets (89, 125, 128, 146). 
In the current study, we show for the first time that phytochemicals from 
apples, one of the most commonly consumed fruits, can extend lifespan in a 
dose-dependent manner in C. elegans. Our findings indicate that C. elegans 
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can live up to 39% longer when fed a diet modified with apple extracts. We 
suggest that the observed anti-aging effects are due to additive and 
synergistic effects of many bioactive compounds found in apples, as we 
proposed earlier (10). Apple phytochemicals possess a variety of bioactivities, 
including antioxidant, anti-proliferative and anti-inflammatory activity, inhibition 
of NF-kB, modulation of cell signaling via MAP kinases and PI3K pathways, 
induction of apoptosis, and regulation of the cell cycle via G1 arrest and 
checkpoint proteins such as Cyclin D1 and Cdk4 (11, 39, 40, 49, 50, 52, 55, 
147). Given this plethora of effects, it is likely that apple phytochemicals act on 
several distinct pathways to extend lifespan. Additionally, quercetin and 
EGCG, two phytochemicals that are found in apples, have been shown to 
extend lifespan in C. elegans (130, 148-150). However, the magnitude of 
lifespan extension for these single phytochemicals (up to 15% for quercetin 
and either 0, 5 or 10% for EGCG depending on the dose and culturing 
conditions) was not as great as that which we observed in animals treated with 
whole apple extracts, suggesting that interaction among various compounds is 
needed to elicit the maximum benefits (10). These results are also in 
agreement with our own preliminary data, which show that quercetin-3-β-D-
glucoside and 2-α-hydroxy-ursolic acid, two of the major phytochemicals 
contained in apples, were not as potent in increasing C. elegans lifespan as 
were whole apple extracts (data not shown). 
In a recent study using blueberry extracts, Wilson et al. reported that 
lifespan and thermotolerance of C. elegans were significantly increased by up 
to 28% and 2.5-fold, respectively (108). Interestingly, the authors did not 
detect a dose-dependent response, nor did they observe any antioxidant 
effects upon induction of mild to severe oxidative stresses, as was previously 
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reported in other in vitro and in vivo models (39, 151, 152). Instead, the effects 
appeared to be mediated by the CaMKII pathway, which modulates osmotic 
stress resistance. Separation of the blueberry extracts revealed that of the 
three major fractions only the proanthocyanidin fraction, and not the 
anthocyanin or chlorigenic acid fractions, contributed to an increase in 
lifespan. This is to some extent surprising because a recent meta-analysis of 
97 studies on bioavailability revealed that, at least in humans, 
proanthocyanidins are the least well-absorbed polyphenols (153). Perhaps in 
C. elegans these compounds have greater bioavailability or are necessary in 
much smaller amounts to elicit their beneficial effects. In contrast, the same 
meta-analysis revealed that isoflavones, catechins and derivates of quercetin, 
which are among the most abundant polyphenols found in apples, are highly 
absorbed. An increase in lifespan often comes at the expense of reduced 
fertility. In our study, we examined the fecundity of the animals and found that 
the total amount of eggs laid did not differ among the treatment and control 
groups. In the blueberry study, because the researchers used a sterile strain 
as a control, such an assessment was not possible. However, pump rate was 
not adversely affected and actually improved, suggesting that the doses tested 
were not toxic and the effects were not due to calorie restriction. 
Another study, by Weigant et al. reported that plant adaptogens of the 
extracts of Eleutherococcus senticosus and Rhodiola rosea increased mean 
lifespan in a dose-dependent manner by over 15%. The researchers 
determined that daf-16, a FOXO-like transcription factor responsible for 
activating many genes involved in cellular stress response, metabolism and 
longevity, translocated to the nucleus upon treatment. In addition, they 
observed the induction of GFP fused to the heat shock promoter. The authors 
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concluded that plant adaptogens may be acting as hormetic agents that exert 
their benefits by inducing mild stress (109). 
In addition to living longer, the animals in our study showed an 
improved quality of life. Healthspan was measured by two biomarkers, 
lipofuscin and motility. Lipofuscin, a fluorescent pigment that accumulates with 
age in many species including humans, was significantly attenuated in animals 
that were pretreated with apple extracts. Apple extracts-treated groups 
showed a two-fold decrease in the accumulation of lipofuscin (Figure 2). 
Motility was also improved following treatment with apple extracts. After 
dividing animals into three groups, 'A' – spontaneous movement, 'C' –no 
movement but still alive, and 'B' – every state of movement in between 'A' and 
'C,' we found that nematodes treated with apple extracts consistently showed 
more youthful and vigorous movement than control animals. The biggest 
change was observed in animals on days 14 and 16 (roughly equivalent to 45-
55 and 55-65 human years of age). We continued to follow apple extracts-
treated animals through day 18 (roughly humans aged at 75-85 years) even 
though more than half of the control animals had already died. Interestingly, 
we observed that the motility of many animals in apple-treated groups on day 
18 were still in classes 'B' and 'A' (data not shown).    
In addition to examining a physical behavior, motility, and a 
physiological characteristic, lipofuscin accumulation, we tested the animals’ 
fitness by examining responses to various stressors. Previous studies have 
established a correlation between longer lifespan and resistance to stresses in 
C. elegans and other animals, including mammals (120, 144, 154). After 
pretreatment with low, moderate and high doses of apple extracts for the first 
two days of adulthood, the animals were challenged with a battery of stressors 
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including heat shock, UV radiation, paraquat-induced oxidative stress, and the 
pathogen P. aeruginosa. We removed the animals from the apple extracts 
plates following the second day to ensure that the effects we observed were 
preventative, as well as to eliminate the possibility of a confounding effect 
between the stressors and treatments. 
Pretreatment with apple extracts greatly improved survival following 
heat shock. This result is consistent with other studies in C. elegans that 
observed enhancement of thermotolerance by plant-derived extracts (108, 
121). Apple extracts may have affected stress signaling pathways via 
modulation of heat shock proteins (hsps) (121). The extracts may have acted 
as mild stressors and affected the activity of these or other stress proteins, 
which promote a generalized, protective stress response. This might explain 
why animals that were pre-exposed to apple extracts had a significantly 
improved survival. Consistent with this hypothesis, data from other 
experiments, which examined C. elegans survival and stress response, 
indicates that beyond their antioxidant properties phytochemicals may 
possess hormetic effects that confer a generalized cellular protective response 
when administered at low doses (109). 
Survival following UV irradiation, which may mimic damage by the sun, 
was also significantly improved in our study after pretreatment with apple 
extracts. UV damage is known to cause skin cancer, accelerate aging, and 
damage DNA. For example, cyclobutane pyrimidine dimers (CPDs) and 
pyrimidine pyrimidone photoproducts are produced after irradiation with UVC 
(200-280 nm) light. DNA repair mechanisms are critical for repairing this 
damage. Natural products that may stimulate these mechanisms include 
resveratrol and curcumin, which were shown to accelerate DNA repair 
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efficiency and unscheduled DNA synthesis in cultured Chinese hamster lung 
fibroblast cells (155). Another possible mechanism by which apple extracts 
may be preventing or repairing UV damage, is regulation at the transcription 
factor level. For example, UVC damage is known to activate transcription 
factor NF-kB (156), which mediates the transcription of many genes including 
those that are involved in cell proliferation, cell survival, and inhibition of 
apoptosis. Expression of these genes may lead to tumorigensis. Previous 
results from our lab have shown that NF- B was inhibited by 2-κ α-hydroxy-
ursolic acid, one of the major phytochemical components found in apple 
extracts (52).  
Aging is associated with an increase in oxidative damage to DNA, 
proteins, and lipids (65). We examined the effects of apple extracts on 
paraquat-induced oxidative stress in C. elegans. After exposing the animals to 
paraquat (10 mM), a superoxide-generating chemical, we found that their 
survival was significantly improved by pretreatment with apple extracts in a 
dose-dependent manner. A superoxide radical is highly reactive and can 
cause damage to lipid membranes, proteins and DNA. Because paraquat is 
regenerated via redox cycling, its in vivo effects can persist as it continuously 
gets reduced and oxidized via electron donors and acceptors to produce 
superoxide. Apple extracts, which as we previously showed possess 
antioxidant activity, may quench the radicals to prevent damage and thereby 
improve survival. This finding may hint at a possible antioxidant mechanism of 
action behind the apple extracts’ life extending properties. Further studies are 
needed to clarify the role of this antioxidative effect. 
Animals were also infected with the pathogen P. aeruginosa to test their 
response to pathogenic attack. Infection occurs by ingestion and, under 
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normal conditions, P. aeruginosa is lethal within 1-3 days. Our results indicate 
that animals pretreated with apple extracts survived up to 35.2% longer, 
hinting at another possible mechanism of lifespan extension – modulation of 
the immune response. In C. elegans, immune response to this Gram-negative 
bacterium is mediated by three major pathways: MAP kinase, dbl-1, and daf-2/
daf16 (157). Inactivation of pmk-1, one of three kinases of the MAP kinase 
pathway, is known to increase susceptibility to infection via upstream signaling 
by the other two MAP kinases, nsy-1 and sek-1 (158). In RAW 264.7 
macrophages, the apple phytochemical quercetin inhibited MAP kinase 
activity81. Specifically, ERK1/2 phosphorylation and p38 MAPK activity were 
blocked upon pretreatment with quercetin (159). One way to test if apple 
extracts act by the same mechanism in C. elegans would be to pretreat the 
pmk-1 mutants with apple extracts and then expose them to P. aeruginosa. If 
the apple extracts are acting via the MAP kinase pathway, this mutant would 
be expected to live longer than the untreated pmk-1 control. Alternatively, the 
apple extracts may be affecting other pathways that modulate innate immunity 
such as dbl-1, which encodes one of four TGF- -like ligands, or β daf-2/daf16, 
the insulin signaling pathway, which also regulates longevity.
We have shown that C. elegans pretreated with apple extracts had 
increased resistance to heat, UV irradiation, oxidative stress and pathogenic 
attack, suggesting that in this organism, in addition to lifespan and health, 
cellular defense and immune system functions are also improved.
2.5  Conclusion
We have shown for the first time that apple phytochemical extracts 
increase lifespan in vivo using the C. elegans aging model. Our results 
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indicate that treatment with apple extracts also improves healthspan, as 
shown by a reduction in lipofuscin accumulation and improved motility. This 
indicates that apple extracts not only extend the lifespan, but also improve the 
quality of life in this model.  In addition, animals were more resistant to heat, 
UV radiation, paraquat-induced oxidative stress, and pathogenic infection with 
the pretreatment of apple extracts, suggesting that cellular defense and 
immune system functions are also improved. Our findings underscore the 
importance of consuming a diet that is rich in fruits and vegetables, including 
apples, rather than single supplements. Future studies are needed to 
elucidate the mechanisms of action, as well as to determine the effects of the 
individual phytochemicals that may be responsible for the health benefits of 
apple extracts. 
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CHAPTER 3
Apple phytochemicals reduce oxidative stress and improve cellular 
stress response in C. elegans
3.1 Introduction
Epidemiological studies have consistently shown that diets rich in fruits 
and vegetables are associated with the prevention of age-associated chronic 
diseases such as cancer, cardiovascular disease and type 2 diabetes (1-3). 
Apples are among the most highly consumed fruits in the U.S. and are the 
number one source of fruit phenolics (39). This diverse group of 
phytochemicals found in a variety of plant foods has been shown to possess 
significant health benefits (10). Previous work from our laboratory has shown 
that apple phytochemical extracts have high antioxidant and anti-proliferative 
activity against colon, liver and breast cancer cells (49, 50). In addition, these 
extracts prevented DMBA-induced mammary tumors in rats, induced G1 arrest 
and decreased the expression of Cyclin D1 and Cdk4 in MCF-7 breast cancer 
cells (11, 55)
Recently, we reported that apple phytochemical extracts extend lifespan 
in the nematode C. elegans by up to 39% in a dose-dependent manner. 
Moreover, we found that two aging markers, lipofuscin and motility were 
improved upon treatment, and that apple phytochemical extracts-treated 
animals showed enhanced resistance to stresses such as heat shock, UV 
irradiation, pathogenic infection and oxidation. 
C. elegans is a popular model in aging research because worms 
experience many behavioral and physiological declines similar to higher 
mammals, including humans (77). As they grow older, worms move more 
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slowly and exhibit sarcopenia - the progressive deterioration of muscle tissue. 
They also become infertile, and accumulate oxidized proteins and lipofuscin, 
both of which are hallmarks of aging in most species. In C. elegans, standard 
assay conditions to study the pharmacology of drugs and interactions with 
genes have been described (105). To date, a variety of human 
pharmacological interventions ranging from vitamins and clinical drugs to 
dietary supplements and phytochemicals have been shown to extend lifespan 
or delay physiological aging and age-related degeneration in C. elegans (61, 
106). Whole-plant phytochemical extracts have also been tested and found to 
have a significant life-extending effect (107-109). Wilson et al. showed that in 
C. elegans, treatment with blueberry extracts increases thermotolerance and 
extends lifespan by up to 28%. Several other studies looked at single 
phytochemicals found in plant foods, including apples. For example, quercetin, 
EGCG, and resveratrol have been shown to extend lifespan in C. elegans 
under some conditions by a variety of molecular mechanisms (89, 130, 148-
150, 160). Previously, we reported that apple phytochemical extracts extended 
lifespan in C. elegans in a dose-dependent manner without toxicity or 
negatively affecting fecundity at the doses tested. The objective of the present 
study was to determine the mechanisms of action by which apple 
phytochemical extracts increase lifespan and improve stress resistance using 
the C. elegans model.
3.2 Materials and methods
3.2.1 Chemicals, reagents and antibodies
Acetone and paraformaldehyde (36%, histology grade) were purchased 
from Fischer Scientific (Pittsburgh, PA). 5-Fluoro-2-deoxyuridine (FUDR) and 
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methyl viologen dichloride hydrate (paraquat) were purchased from Sigma-
Aldrich (St. Louis, MO).  Collagenase type IV was purchased from Sigma-
Aldrich (St. Louis, MO). Anti-4-hydroxy-2-nonenal monoclonal antibody was 
purchased from Genox Corporation (Baltimore, MD). Alexaflour 546 goat-anti-
mouse antibody was purchased from Invitrogen Corporation (Carlsbad, CA). 
3.2.2 Extraction of apple phytochemicals
Fresh apples of the Red Delicious variety were purchased from Cornell 
Orchards (Cornell University, Ithaca, NY) and extracted using the method 
previously reported by our laboratory (50). Briefly, whole apples were sliced, 
blended in ice-chilled 80% acetone, homogenized and rotary evaporated 
under vacuum at 45°C until approximately 90% of the filtrate had been 
evaporated. The concentrate was re-suspended in water, and no other solvent 
remained in the extract. The extracts have been characterized based on 
bioactivity-guided fractionation and structure identification using HR-MS, 1D 
and 2D NMR, and X-ray diffraction analysis using the method we reported 
previously (40). Apple phytochemical extracts were frozen at –80oC until use.
3.2.3 Strains, maintenance and culturing of nematodes
Strains of C. elegans used were: Bristol N2 (wild-type), daf-16(mgDf47), 
sir2.1(ok434), eat-2 (ad465), mev-1 (kn1), glp-1 (e2141), CL2070 [dvIs70(hsp-
16.2::gfp; rol-6(su1006))], CL2166 [dvIs19(pAF15(gst-4::GFP::NLS))], and 
CF1553 [muIs84[pAD76(sod-3::GFP)]]. All strains were generously shared by 
the laboratory of Dr. S.S. Lee (Cornell University, Ithaca, NY). Animals were 
maintained at 20ºC on petri dishes containing nematode growth medium 
(NGM) seeded with live E. coli strain OP50 as the food source according to 
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the general procedures outlined by Brenner (137). 
3.2.4 Lifespan assays
Several gravid adult nematodes were placed on NGM plates seeded with 
E. coli strain OP50 and allowed to lay eggs at 20ºC for approximately 6 hours 
to obtain a synchronous population. After 6 hours, the nematodes were 
removed and the plates were placed back at 20ºC until the progeny reached 
young adulthood (about 72 hours). On day 0 of the experiment, these young 
adult nematodes were transferred to 35 mm NGM petri dishes containing 
either no apple phytochemical extracts or the appropriate doses of dissolved 
apple phytochemical extracts and 50 µM of 5-fluoro-2-deoxyuridine (FUDR) to 
prevent progeny production. Plates were then dried in a sterile hood, seeded 
with 100 µL of 3-fold concentrated, saturated E. coli OP50 culture, and dried 
again. Animals were transferred every other day to fresh extracts or control 
plates until day 8 of adulthood. Lifespan of mutant strains was always 
conducted in parallel with the wild-type N2 strain to verify the potency of the 
extracts and to compare the magnitude of the differences between mutant and 
wild-type animals. Animals were scored daily or every other day by gentle 
prodding with a platinum wire. Those animals that failed to move were scored 
as dead. Animals, which exhibited bagging, exploded or crawled off the plates, 
were censored. Statistical analyses were performed using SPSS statistical 
software Kaplan-Meier Survival function; p-values were obtained using the 
log-rank test. Unless otherwise indicated, each lifespan experiment was 
repeated 2-3 times and a representative trial is shown. Unless otherwise 
indicated, all experiments were performed at 20ºC. 
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3.2.5 4-HNE assay 
4-HNE was measured according to the method described by Loer et al. 
(161) and Wilson et al. (108). Briefly, animals were washed off petri plates with 
M9 buffer, collected into eppendorf tubes and then washed free of bacteria 
with M9. The supernatant was removed and 500 µL of 4% paraformaldehyde 
was added. Animals (20-30 per tube) were fixed overnight at 4°C. The 
following day, animals were washed 3 times in 1 mL of 0.5% TX-100/PBS and 
incubated at 37°C overnight in 500 µL of 5% BME/1%TX100/0.1M Tris, pH 
7.4, with gentle rocking. The following day, animals were washed twice with 
1mL of 1% TX-100/0.1M Tris, pH 7.4, washed once with 1mL collagenase 
buffer (1mM CaCl2, 1% Triton X-100, 0.1M Tris, pH 7.4), and incubated for 45 
minutes with 2000 units/mL of Collagenase Type IV. Then, the animals were 
washed 3 times in 1mL 0.5% TX-100/PBS and blocked for 1 hour in 200 µL of 
1% BSA/0.5% TX-100/PBS (AbA) at 4°C. Following blocking, animals were 
incubated with 100 µl Anti-4-HNE primary antibody (1:100 dilution) in AbA for 
2 hours at room temperature, washed 2 times in 1 ml 0.5% TX-100/PBS and 
incubated overnight with 100 µL Alexaflour 546 goat-anti-mouse secondary 
antibody (1:100 dilution) in 0.1% BSA/0.5% TX-100/PBS (AbB) at 4°C. The 
following day, animals were wash 3 times in 1 mL of 0.5% TX-100/PBS and 
washed once in 1 mL of AbB and left to destain at 4°C in AbB for 24-48 hours. 
After destaining, individual nematodes were mounted onto 2% agarose slides 
for fluorescence photomicrography. Slides were visualized with the DM 5000 
Leica Microscope using the appropriate filter set. Images were captured using 
a Hamamatsu ORCA-ER camera with OpenLab software. Quantification of 
immunofluorescence intensity was done densitometrically by tracing around 
each animal’s pharynx terminal bulb and determining average pixel intensity 
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using imageJ freeware (NIH) (162).
3.2.6 Stress response induction and GFP visualization
Synchronous populations of CL2166 and CF1553 animals were 
obtained using the egg lay method as described above. Upon reaching young 
adulthood GFP animals were placed on petri dishes containing either no or 
appropriate amounts of apple phytochemical extracts and maintained at 20°C. 
Following 48 hours of treatment, animals were anesthetized in 20 µM sodium 
azide and mounted on 2% agarose slides for visualization. For the CL2070 
strain, animals were treated with apple phytochemical extracts for 48 hours 
starting from young adulthood, heat-induced at 35°C for 2 hours and returned 
to 20°C to recover. 20 hours following heat induction, animals were 
anesthetized and mounted on slides as above. Slides were visualized using 
the Leica DM5000B Microscope (Bannockburn, IL), with the appropriate GFP 
filter. GFP fluorescence was captured using a Hamamatsu ORCA-ER camera 
with the OpenLab software. Using ImageJ freeware (NIH) (162), the 
fluorescence intensity of 20-30 animals per group was measured as the sum 
intensity of all pixels within a 75-255 threshold in 8-bit grayscale images 
containing a single worm each.  
3.2.7 Statistical analyses 
Survival data were analyzed using SPSS version 16 for Windows 
(SPSS Inc., Chicago, IL) Kaplan-Meier Survival function, Kaplan-Meier 
Estimator of means, and log-rank test. All other analyses were done using 
Minitab statistical software (State College, PA). A p- value < 0.05 was 
considered to be statistically significant among treatments in multiple 
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comparisons for all statistical tests performed. Data for 4-HNE and stress 
response induction were analyzed using One-way ANOVA (assuming equal 
variance), with Tukey’s multiple comparison test for differences among groups 
where appropriate. A p- value < 0.05 was considered to be statistically 
significant Graphs were plotted with the SigmaPlot version 10 for Windows 
software (Systat Software Inc., San Jose, CA). 
3.3 Results
3.3.1 Effect of apple phytochemicals on insulin signaling, sirtuin and 
mitochondrial respiration mutants 
In C. elegans the modulation of insulin signaling, sirtuins, and oxidative 
stress have been shown to affect lifespan. To determine if apple extracts 
extend lifespan by any of these pathways, we used mutant strains of daf-
16(mgDf47), sir2.1(ok434) and mev-1(kn1) to perform lifespan analyses in 
parallel with wild-type N2 animals. daf-16 is a transcription factor which is 
activated under conditions of stress such as starvation, overcrowding or 
elevated oxidation. It is regulated by insulin signaling and binds to the 
promoters of many genes responsible for stress response, metabolism, fat 
storage and lifespan. daf-16 mutants are short-lived. sir-2.1 belongs to the 
silent information regulator (SIR) family of proteins known as the sirtuins, 
which are conserved in yeast, worms, flies and mammals. The sirtuins are part 
of a family of NAD+-dependent deacetylases that play an important role in 
gene silencing, DNA repair and aging in a diverse group of organisms (89). In 
C. elegans, sir-2.1 overexpression leads to long life, this effect is dependent 
on daf-16 (91). mev-1 is an mitochondrial mutant with a mutation in the 
cytochrome b subunit of complex II. It is hypersensitive to oxidative stress and 
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short-lived. 
The mean lifespan of N2 animals was 17.01±.30 days. After 
administering 5, 10 and 20 mg/mL of apple phytochemical extracts, the mean 
lifespan increased to 23.81±.65, 22.26±.44 and 20.72±.36 days, respectively. 
The dose of 5 mg/mL produced the highest increase in lifespan of 40% over 
the control (Table 3.1). Likewise, daf-16 animals lived an average of 
15.80±.25, 19.08±.30, 19.38±.30 and 19.80±.40 days for 0, 5, 10 and 
20mg/mL groups, respectively. This represents an increase of up to 25.3% in 
a dose-dependent manner over the 0 mg/mL daf-16 control (Table 3.1). 
Similarly, sir2.1 animals survived for 17.65±.29, 22.75±.43, 21.82±.43, 
20.76±.36 days in 0, 5, 10 and 20 mg/mL groups. The 5 mg/mL dose yielded 
the highest increase in lifespan of up to 28.9% over the 0 mg/mL sir2.1 control 
(Table 1). Finally, the lifespan of mev-1 animals was 14.63±.50, 16.57±.47, 
16.78±.50, 17.75±.52 days for 0, 5, 10 and 20 mg/mL groups, respectively. 
This represents an increase of up to 21.3% in a dose-dependent manner over 
the 0 mg/mL mev-1 control (Table 3.1). It is of note that many lifespan 
experiments showed maximum benefit at lower doses.
3.3.2 Effect of apple phytochemicals on calorie restricted animals 
We examined the effect of apple phytochemical extracts on the lifespan 
of the calorie restricted eat-2 animals. These animals have a pumping defect, 
which causes them to pump less frequently and thus calorie restrict 
themselves. eat-2 worms are long-lived compared to the wild-type. The 
lifespan of animals on 0, 5, 10 and 20 mg/mL of apple phytochemical extracts 
was 22.30±.51, 31.85±.83, 33.53±.63, 27.03±.52 days, respectively. The dose 
of 10 mg/mL showed the highest increase in lifespan of 50.4% over the eat-2 
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control (Table 3.1). In parallel, we performed N2 lifespan and found that mean 
lifespan was 16.08±.28, 24.35±.49, 25.58±.70, 25.09±.68 days for 0, 5, 10 and 
20 mg/mL, respectively. The dose of 10 mg/mL showed the highest increase 
in lifespan of 59.1% over the control (Table 3.1).
3.3.3 Effect of apple phytochemicals on stress response induction 
The induction of superoxide dismutase, glutathione-S-transferase and 
the small heat shock protein promoter hsp16.2 was examined using a GFP 
reporter system. Apple phytochemical extracts significantly decreased the 
activity of the sod-3 reporter in all treatment groups versus the 0 mg/mL 
control by up to 70% (Figure 3a; p<0.01, One-way ANOVA). Likewise, apple 
phytochemical extracts decreased the activity of the gst-4 promoter in 5 and 
10 mg/mL groups versus the 0 mg/mL control by up to 35% (Figure 3b; 
p<0.01, One-way ANOVA). In contrast, apple phytochemical extracts 
increased the activity of the hsp16.2::promoter by up to 30% versus the 0 mg/
mL control (Figure 3c; p<0.01, One-way ANOVA). 
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Table 3.1 Effect of apple phytochemical extracts on mean lifespan of wild-type 
and mutant C. elegans nematodes.
Genotype
Treatment 
(mg/mL) N
Mean 
Lifespan±SEM
(days)*
∆*
*
p-
value 
vs. 
control
% of 
Control
0 (control) 80 17.01±.30 a N.A. 100.0
N2 (wild-
type) 5 74 23.81±.65b b <0.001 140.0
parallel to
daf-16, 
sir2.1,  
mev-1
10 91 22.26±.44 c <0.001 130.9
20 85 20.72±.36 d <0.001 121.8
0 55 16.08±.28 a N.A. 100.0
N2 parallel 
to eat-2 5 80 24.35±.49 b <0.001 151.4
10 81 25.58±.70 b <0.001 159.1
20 79 25.09±.68 b <0.001 156.0
0 87 15.80±.25 a N.A. 100.0
daf-16 
(mgDf47) 5 90 19.08±.30 b <0.001 120.8
10 93 19.38±.30 b <0.001 122.7
20 79 19.80±.40 b <0.001 125.3
0 72 17.65±.29 a N.A. 100.0
sir2.1(ok4
34) 5 97 22.75±.43 b <0.001 128.9
10 82 21.82±.43 b <0.001 123.6
20 78 20.76±.36 c <0.001 117.6
0 73 22.30±.51 a N.A. 100.0
eat-
2(ad465) 5 75 31.85±.83 b <0.001 142.8
10 68 33.53±.63 b <0.001 150.4
20 59 27.03±.52 c <0.001 121.2
0 69 14.63±.50 a N.A. 100.0
mev-
1(kn1) 5 68 16.57±.47 b 0.016 113.3
10 68 16.78±.50 b <0.01 114.7
20 77 17.75±.52 b <0.001 121.3
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Table 3.1 (Continued)
* Mean ± SEM based upon Kaplan-Meier estimator
** Values with no letters in common within each column are significantly 
different; a p-value of < 0.05 was considered to be statistically significant 
based on chi-squared log-rank test).
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Figure 3.1 Effect of apple phytochemical extracts on adult lifespan of N2 wild-
type animals done in parallel with daf-16(mgDf47), sir2.1(ok434) and mev-
1(kn1) mutant animals (see figures below). N2 day 1 young adult wild-type N2 
animals were treated with the indicated concentrations of apple extracts or no 
extract and monitored for survival starting on the first day of adulthood. 
Animals that were exposed to three levels of apple extracts survived 
significantly longer than those that were not (p<0.001 for 0 mg/mL compared 
to each treatment group; log-rank test; see Table 3.1). The experiment was 
repeated multiple times and a representative trial is shown.
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 Figure 3.2 Effect of apple phytochemical extracts on adult lifespan of daf-
16(mgDf47) animals. Day 1 young adult daf-16(mgDf47) animals were treated 
with the indicated concentrations of apple extracts or no extract and monitored 
for survival starting on the first day of adulthood. Animals that were exposed to 
three levels of apple extracts survived significantly longer than those that were 
not (p<0.001 for 0 mg/mL compared to each treatment group; log-rank test; 
see Table 3.1). The experiment was repeated multiple times and a 
representative trial is shown.
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Figure 3.3 Effect of apple phytochemical extracts on adult lifespan of 
sir2.1(ok434) animals. Day 1 young adult sir2.1(ok434) animals were treated 
with the indicated concentrations of apple extracts or no extract and monitored 
for survival starting on the first day of adulthood. Animals that were exposed to 
three levels of apple extracts survived significantly longer than those that were 
not (p<0.001 for 0 mg/mL compared to each treatment group; log-rank test; 
see Table 3.1). The experiment was repeated multiple times and a 
representative trial is shown.
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Figure 3.4 Effect of apple phytochemical extracts on adult lifespan of mev-
1(kn1) animals. Day 1 young adult mev-1(kn1) animals were treated with the 
indicated concentrations of apple extracts or no extract and monitored for 
survival starting on the first day of adulthood. Animals that were exposed to 
three levels of apple extracts survived significantly longer than those that were 
not (p<0.05 for 0 mg/mL compared to each treatment group; log-rank test; see 
Table 3.1). The experiment was repeated multiple times and a representative 
trial is shown.
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Figure 3.5 Effect of apple phytochemical extracts on adult lifespan of N2 
animals done in parallel to eat-2(ad465). Day 1 young adult N2 animals were 
treated with the indicated concentrations of apple extracts or no extract and 
monitored for survival starting on the first day of adulthood. Animals that were 
exposed to three levels of apple extracts survived significantly longer than 
those that were not (p<0.001 for 0 mg/mL compared to each treatment group; 
log-rank test; see Table 3.1). The experiment was repeated multiple times and 
a representative trial is shown.
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Figure 3.6 Effect of apple phytochemical extracts on adult lifespan of eat-
2(ad465) animals. Day 1 young adult eat-2(ad465) animals were treated with 
the indicated concentrations of apple extracts or no extract and monitored for 
survival starting on the first day of adulthood. Animals that were exposed to 
three levels of apple extracts survived significantly longer than those that were 
not (p<0.001 for 0 mg/mL compared to each treatment group; log-rank test; 
see Table 3.1). The experiment was repeated multiple times and a 
representative trial is shown. 
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0 mg/mL SOD-3::GFP    2.5 mg/mL SOD::GFP      5 mg/mL SOD::GFP      10 mg/mL::SOD-3::GFP
Figure 3.7 Effect of apple phytochemical extracts on SOD-3::GFP promoter 
activity. N=23, 19, 4 and 22 animals for 0, 2.5, 5 and 10 mg/mL groups, 
respectively; p<0.01 for 0 mg/mL versus each apple extract group; One-way 
ANOVA, Tukey’s multiple comparisons; all other comparisons not significant). 
Bars with no letters in common represent groups that are statistically 
significantly different. Values are expressed as mean relative fluorescence ± 
SD. See Appendix II for additional statistical analysis. 
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   0 mg/mL GST-4::GFP     2.5 mg/mL GST-4::GFP    5 mg/mL GST-4::GFP           10 mg/mL GST-4::GFP
Figure 3.8 Effect of apple phytochemical extracts on GST-4 promoter activity 
(N = 33, 28, 28 and 27 animals for 0, 2.5, 5 and 10 mg/mL groups, 
respectively; p<0.01 for 0 mg/mL vs. 5 mg/mL and for 0 mg/mL vs. 10mg/mL 
groups; p=0.044 for 2.5 mg/mL vs. 5 mg/mL groups; One-way ANOVA, 
Tukey’s multiple comparisons). Bars with no letters in common represent 
groups that are statistically significantly different. Values are expressed as 
mean relative fluorescence ± SD. See Appendix II for additional statistical 
analysis.
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        0 mg/mL                  0 mg/mL + HS        2.5 mg/mL + HS      5 mg/mL + HS      10 mg/mL +HS
Figure 3.9 Effect of apple phytochemical extracts on Hsp16.2 promoter 
activity (n=24, 23, 27 and 20 animals for 0, 2.5, 5 and 10 mg/mL groups, 
respectively; p<0.01 for 0 vs. 10 mg/mL, One-way ANOVA, Tukey’s multiple 
comparisons; all others nonsignificant). Bars with no letters in common 
represent groups that are statistically significantly different. Values were 
expressed as mean relative fluorescence ± SD. See Appendix II for additional 
statistical analysis.
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Figure 3.10 Effect of apple phytochemical extracts on 4-HNE accumulation in 
C. elegans. N 10 animals per group. There were no significant differences in≤  
the accumulation of 4-HNE lipid peroxidation byproduct. (p=.193 0 mg/mL 
versus all treatment groups; One-way ANOVA and p<0.001 0 mg/mL N2 
versus 0 mg/mL mev-1(kn1) positive control; One-way ANOVA; Tukey’s 
multiple comparisons). A p-value < 0.05 was considered to be significantly 
different. See Appendix II for additional statistical analysis.
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3.4 Discussion
This study sought to characterize the enhanced lifespan and stress 
response mechanisms of apple phytochemical extracts using the C. elegans 
model. We performed a genetic screen of mutant animals lacking genes in the 
five major longevity pathways. We reasoned that lifespan extension with apple 
phytochemical extracts would be abrogated in animals lacking a gene in a 
pathway that is required for this effect. Our results indicate that, in C. elegans, 
lifespan extension with apple phytochemical extracts is most likely not due to 
insulin signaling, sirtuin activity, signaling from the germ line or calorie 
restriction. While the increase in lifespan of daf-16 and sir2.1 mutant strains 
we observed was somewhat smaller than that of N2 animals, we believe that 
these differences were within the acceptable range of variation between 
experiments. However, we cannot exclude the possibilities that these 
differences are due to differential metabolism of the compounds, deleterious 
pleiotropic interactions between the mutation and phytochemicals, or other 
physiological differences between the wild-type and mutant animals (112). 
Thus, the possibility remains that these pathways may be at least partially 
responsible for mediating the effects of apple phytochemical extracts. 
Interestingly, previous reports have shown that other dietary phytochemicals 
such as resveratrol, a stilbene found in grapes, peanuts and other plant foods, 
and quercetin, a flavonoid found predominantly in apples and onions, exert 
their effects via modulating sirtuin and insulin signaling, respectively. Our 
findings suggest that apple phytochemicals do not act mainly via the major 
longevity pathways, but instead have a unique mode of action owing to the 
variety of compounds they contain.
Apple phytochemical extracts have potent antioxidant activity in vitro (39, 
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49). Previously, we showed that apple phytochemical extracts also have 
antioxidant effects in vivo in a paraquat-induced model of oxidative stress. To 
further characterize the possible antioxidant effects of apple phytochemical 
extracts in C. elegans, we used the mev-1(kn1) strain, which has a missense 
mutation in the cyt-1 gene coding for the succinate dehydrogenase 
cytochrome b large subunit of complex II. The animals in this strain are 
hypersentive to oxygen, produce excessive amounts of superoxide anions in 
their mitochondria and have a shortened lifespan. In addition, they also have 
lower superoxide dismutase levels, reduced glutathione levels, and higher 
lactate concentrations (96, 163, 164). Our results show that mev-1 animals 
treated with apple phytochemical extracts had an increase in lifespan similar 
to that of wild-type animals. We interpret this result to mean that apple 
phytochemical extracts alleviated damage caused by oxidative stress, in 
particular superoxide anions, and thereby improved the survival of mev-1 
animals. This biochemical effect is separate from the genetic effect of the cyt-
1 gene, which plays a key role in energy metabolism and superoxide anion 
production (163). 
Damage from oxidative stress can affect DNA, proteins, lipids, and other 
macromolecules. To further investigate the type of oxidative damage that may 
be attenuated by apple phytochemical extracts, we examined levels of 4-
Hydroxy-2-Nonenal (4-HNE) in wild-type control and wild-type apple 
phytochemical extracts treated animals. 4-HNE is a byproduct of lipid 
peroxidation, which results from ROS peroxidation damage to polyunsaturated 
fatty acids. It has been shown to accumulate with age in many species.  In C. 
elegans increasing the rate of metabolism of 4-HNE increases lifespan (71, 
165). Our results did not show a significant effect of apple phytochemical 
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extracts on the amount of 4-HNE relative to the control (Figure 4c). 
Interestingly, Wilson et al. have reported that in C. elegans, blueberry 
polyphenols decrease the levels of 4-HNE, showing that at least some dietary 
polyphenols can attenuate 4-HNE in this model (108).
Increased lifespan often correlates with increased stress resistance 
(120). Previously, we showed that survival upon challenge with oxidative 
stress, UV irradiation, pathogenic infection and heat stress were all improved 
following treatment with apple phytochemical extracts. To further characterize 
the ability of animals to cope with stress, we examined the expression of 
genes that are associated with oxidative stress response by looking at GFP 
expression of sod-3 and gst-4 reporter strains. These strains contain GFP 
driven by the superoxide dismutase (sod-3) and glutathione-S-transferase 
(gst-4) promoters, respectively. Since both sod-3 and gst-4 are induced by 
oxidative stress, we used the expression of GFP as a proxy of ROS damage.
sod-3 is one of five isoforms of superoxide dismutase found in C. 
elegans. It is expressed in the mitochondrial matrix where it quenches 
superoxide anions. The other superoxide dismutases are the mitochondrial 
MnSOD sod-2, two cytosolic Cu/Zn isoforms: sod-1 and sod-5, and an 
extracellular Cu/ZnSOD, sod-4. SOD-3::GFP localizes predominantly to the 
pharynx and intestine. Honda et al. have shown that deletion of the two 
MnSODs causes increased sensitivity to paraquat and hyperoxia, but has no 
effect on lifespan, or even increases it in some cases (166). Similarly, others 
have shown that deleting all five sod enzymes increases oxidative stress, but 
does not shorten lifespan, and even lengthens it in some cases (67, 68). 
However, in long-lived insulin signaling daf-2 mutants, daf-16 translocates into 
the nucleus where it directly binds the SOD-3 promoter and upregulates the 
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SOD-3 gene. While this effect appears not to be directly causal of enhanced 
lifespan (68), sod-3 still reduces oxidative damage and can thereby promote 
health and lifespan indirectly. 
In our experiments, apple phytochemical extracts reduced the activity of 
the sod-3 promoter. We propose that apple phytochemical extracts may 
protect against deleterious oxidative damage normally mitigated by sod-3 and 
thus lead to a decreased need for this part of the endogenous antioxidant 
system. In agreement with this, we previously found that healthspan of our 
animals, as indicated by lipofuscin attenuation and motility, was also 
significantly improved. Since we did not address the functional interaction 
between the apple phytochemical extracts and sod-3 directly, the possibility 
exists that apple phytochemical extracts may act by repressing this antioxidant 
gene directly rather than by attenuating oxidative damage. However, taken 
together with our mev-1 survival and previous paraquat results the latter 
seems to be the more likely possibility. 
Similarly, results with gst-4::GFP showed that the induction of this 
transgene was reduced upon exposure to apple phytochemical extracts.  gst-4 
is a glutathione-S-transferase which functions in the detoxification of 
endogenous OS products and xenobiotics.
We propose that, antioxidant compounds from apple phytochemical extracts 
act to mitigate oxidative damage, thus reducing the need for the activity of gst-
4. As with sod-3, however, functional effects cannot be ruled out. 
In a previous experiment, we found that thermotolerance was improved 
upon treatment with apple phytochemical extracts. Heat shock response is a 
highly conserved process that functions to maintain cellular homeostasis. 
Therefore, we examined the small heat shock protein hsp16.2, which is 
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upregulated under a variety of stress conditions including thermotolerance, 
oxidative stress and detoxification of some environmental toxins. hsp16.2 has 
also been shown to interact with intracellular human beta amyloid peptide, 
likely as a stabilizing chaperone protein, making it of interest in studies 
involving models of Alzheimer’s disease.
 Hsp-16.2::GFP expression is strongest in the intestine and the pharynx 
(167). Because hsp16.2 is induced only under conditions of stress, especially 
heat and oxidative stress, we exposed the animals to heat shock prior to 
visualizing GFP activity. After treating the hsp16.2::GFP animals with apple 
phytochemical extracts, we observed an induction of the hsp-16.2 promoter. 
We propose that under conditions of stress, apple phytochemical extracts 
produce a heat stress response via hsp16.2, a protein that can mitigate 
byproducts of oxidative and environmental stresses, and endogenous and 
exogenous toxins, as well as stabilize misfolded proteins.This idea is 
consistent with our previous findings that apple phytochemical extracts treated 
animals survive longer following heat stress than do controls animals. The 
induction of hsp16.2 under conditions of stress may also explain the improved 
response to other stressors that were tested such as paraquat-induced 
oxidative stress and UV irradiation. This idea is in agreement with previously 
published reports, which found that plant extracts, including those of plant 
adaptogens and Ginko biloba upregulated hsp16.2  in the C. elegans model 
(109, 168).  
3.5 Conclusion
We propose that the activity of apple phytochemical extracts is not 
dependent on the insulin signaling pathway, sir2.1, or calorie restriction. 
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Instead, the effects appear to be mediated by attenuation of ROS damage. 
This view is supported by the increased lifespan of the mev-1 mutant, 
increased survival upon induction of paraquat-induced oxidative stress and a 
reduction of induction of the sod-3 and gst-4 GFP promoters. However, 
because we saw no effect on the attenuation of 4-HNE, we cannot definitively 
conclude that apple phytochemical extracts act to mitigate oxidative damage 
at the macromolecular level. Further evidence such as protein and DNA 
oxidation data, would be needed before such a conclusion could be reached. 
In addition, increased induction of hsp16.2 upon conditions of stress likely 
contributes to a general improvement of cellular detoxification and stress 
response, and explains improved survival under conditions of heat shock, 
oxidation stress, and UV irradiation. Our findings are in agreement with the 
‘green theory of aging’ which posits that molecular junk, including oxidation 
byproducts, accumulates with age and, if left undetoxified by phase I and II 
systems, leads to the molecular damage associated with aging. In addition, a 
recent report by Benedetti et al. showed that, out of a wide spectrum of 
antioxidants, only a select few extend lifespan of C. elegans. Of these, one 
compound showed an induction of CYP35::GFP, a phase I detoxification gene 
associated with the xenobiotic response (121). Further studies into the 
potential type(s) of oxidative damage that may be reduced, as well as other 
potential mechanisms of action that may be involved would be of great 
interest. Additionally, it would also be interesting to elucidate the individual 
combinations of phytochemicals that are responsible for increasing lifespan 
and improving stress response.   
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CHAPTER 4
Conclusions and future perspectives
Aging research has made tremendous strides in the last 20-30 years. It 
was shown that the aging process is plastic, and that this plasticity can be 
manipulated by altering genes, the physical environment and diet. This latter 
manipulation in particular has seen a great deal of interest and surge in 
publications in recent years, especially in the model C. elegans. In this model, 
a variety of treatments including vitamins, clinical drugs, synthetic antioxidants 
and phytochemicals, have shown that it is possible to not only extend lifespan 
but also reduce age-related decline and pathologies such as sarcopenia and 
accumulation of human beta amyloid peptiedes which are associated with 
Alzheimer’s disease. C. elegans is one of the most popular and robust, 
simplest whole-animal model systems that has been employed in the study of 
aging. Results from C. elegans taken together with those of other organisms 
such as Saccharomyces cerevisiae, D. melanogaster, Mus musculus and 
primates, can provide a powerful comparative approach in the study of 
nutrition, natural products and lifespan.   
Apples are the second most highly consumed fruit and the number one 
source of phenolics in the United States. Apple phytochemicals have been 
shown to have a wide variety of health benefits including antioxidation, 
antiproliferation and modulation of a variety of molecular targets such as NF-
kB and AP-1. The work presented here shows for the first time that apple 
phytochemicals can increase lifespan and healthspan in vivo using C. 
elegans. This increase appears to be dose-dependent, at least  some of the 
time and is accompanied by an improvement in motility and attenuation of 
lipofuscin. In addition, I have shown that apple phytochemicals increase 
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resistance to various stresses such as oxidative, heat, UV, and pathogenic 
infection. The mechanism by which apple phytochemicals exert their effects do 
not appear to be through insulin signaling, sirtuin sir2.1, calorie restriction or 
germ line signaling. Instead, the evidence points to attenuation of oxidative 
stress and a generalized cellular stress resistance response as the two 
mechanisms responsible for the observed effects. This conclusion is 
supported by increased lifespan of the mev-1 mutant, resistance to paraquat-
induced oxidative stress and reduced levels of expression of sod-3::GFP and 
gst-4::GFP, two enzymes responsible for sttenuating oxidative damage. In 
addition, induction of the hsp16.2 promoter was increased following heat 
stress suggesting that there is a protective and possibly generalized increase 
in the cellular stress response. These two processes likely contribute to the 
increase in lifespan, healthspan and stress resistance that I observed in C. 
elegans in this study. The examination of additional markers of oxidative 
stress such as DNA and protein oxidation would be of great interest. 
 Apples possess a wide variety of compounds, the most bioactive of 
which are in the flavonoids group. I tested two such compounds, quercetin-β-
D-glucoside and 2-α-ursolic acid and found that both increased lifespan of C. 
elegans. However, I did not observe a dose-response and the increase in 
lifespan was not as great as that for the whole apple phytochemical extracts. 
This suggests that additive and/or synergistic interactions between different 
compounds are needed to elicit the maximum effect. It is worth pointing out 
that the anti-aging activity of apples is unique. At the onset of my research, I 
examined cranberry extracts and found that there was no effect on aging in C. 
elegans at the doses tested. In addition, only one other (berry) fruit, 
blueberries, have been shown to extend lifespan. While this study was the first 
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of its kind and is highly significant, apples are much more highly consumed 
than blueberries and are thus of more relevance. Additionally, the bioactive 
compounds of blueberries, that were found to exert the anti-aging effects on 
C. elegans, the proanthocyanidins, have low biovailability in humans (169). 
Also, a wild blueberry juice preparation was used for fractionation, whereas 
most blueberries and blueberry juices purchased by consumers are of the 
commercial blend and likely have different phytochemical profiles. 
My findings are significant because while it has been known for a long 
time that apples are “good for you,” the anti-aging, healthspan, and stress 
resistance effects of apples and their mechanisms in vivo have never been 
previously published. However, further examination into additional 
mechanisms of action would be of great interest. 
For example, to better characterize the type and extent of oxidative 
damage, we could use the skn-1 mutant. This gene is involved in the oxidative 
stress response of C. elegans. SKN-1 is a gene related to the vertebrate Nrf 
proteins, and a transcription factor that acts in parallel to DAF-16 to promote 
the expression of phase II detoxification enzymes, especially in response to 
oxidative stress. SKN-1 is a target of IIS, but acts independently of DAF-16. 
Like DAF-16, SKN-1 is sequestered in the cytoplasm until it is activated by p38 
phosphorylation under conditions of stress. Upon activation, SKN-1 
translocates to the nuclei of intestinal cells where it binds to the promoters of 
and turns on a variety of target genes, which act to reduce oxidative stress. If 
the lifespan increase of skn-1 mutants is abrogated with respect to N2, this 
might suggest that apple phytochemicals act through this transcription factor. 
If this were the case, we could examine the relative expression of specific 
targets of SKN-1 such as promoters of gcs-1, gst-4, gst-7, gst-5 and gst-10 
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using RT-PCR. Additionally, if GFP strains of SKN-1 and/or its target genes 
exist, it would be facile to examine the expression pattern of these reporter 
strains. It might also be of interest to measure the actual levels of ROS inside 
the worms and compare these between controls and apple treated animals. 
Recently, it was reported that electron paramagnetic resonance spectroscopy 
was used for this purpose in C. elegans  (170). This technique takes 
advantage of the correlation between free iron species and free superoxide 
anions inside the cell. By measuring the amount of iron, it is possible to gauge 
the levels of superoxide and its damage. 
In addition, RT-PCR of sod-3 and gst-4 could be carried out to 
confirm the GFP results of the reduced activity of these two genes. Moreover, 
it would be worthwhile to examine the other SOD genes (there are a total of 
five in C. elegans) and other GST genes to see if they are also involved in 
reducing oxidative damage upon treatment with apple phytochemical extracts 
and to what extent.
Other potential experiments include using DAF-16::GFP to test whether 
this transcription factor is activated and gets into the nucleus. While my 
lifespan data suggest that this is probably not the case, the increase in 
lifespan that was observed was smaller than that of N2 animals leaving the 
possibility that DAF-16 plays some role in the effects of apple phytochemical 
extracts. This experiment would be especially worthwhile in light of the fact 
that Saul et al. have reported that quercetin, one of the flavonoid components 
of apples can activate DAF-16 and cause it to translocate into the nucleus 
(160). 
My findings point to two potential mechanisms, mitigation of oxidative 
stress and generalized cellular protection, to slow aging, and improve 
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healthspan and stress resistance. However, it is likely that other mechanisms 
are present. To get a global view of the anti-aging and other potential effects 
of apple phytochemicals on C. elegans, it would be useful to carry out a 
microarray experiment at different time points to identify all the genes that are 
up and down regulated. In addition, it would be interesting to test other 
flavonoid compounds that are found in apples and to see if they synergize to 
delay aging. 
In conclusion, I have shown that beyond their known healthful 
properties such as high contents of Vitamin C, and pectin, which has been 
shown to lower cholesterol, apples also have anti-aging benefits in vivo, in the 
C. elegans model. My results implicate the antioxidant and cellular stress 
resistance pathways as two potential modes of action. However, given recent 
findings in the field of free radical biology, it is important to keep in mind that 
antioxidants are not a panacea for slowing down the aging process and 
increasing lifespan. Moreover, the function of antioxidants is not to remove 
oxidants entirely, but instead to keep them at an optimum level. Therefore, the 
anti-aging and stress resistance mechanisms of apple phytochemicals warrant 
further study. 
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APPENDIX I
Effects of single phytochemicals quercetin-3-β-D-glucoside and 2-α-
ursolic acid found in apples on the lifespan of C. elegans.
Many of the health benefits of fruits and vegetables have been 
proposed to be due to the synergistic effects of the phytochemicals they 
contain (4). To this end, I screened two individual phytochemicals found in 
apples, quercetin-3-β-D-glucoside (Figure I.1) and 2-α-ursolic acid (Figure I.2). 
These compounds have been isolated from the apple peels using bio-guided 
fractionation (40). I find that at some of the doses tested these compounds still 
extend lifespan, but to a lesser extent than whole apple phytochemical 
extracts (Figure I.3). Moreover, in the case of 2-α-ursolic acid, the middle and 
high doses showed a toxic effect on lifespan. Therefore, it appears that there 
is an optimum range of doses that can elicit beneficial effects, and there is a 
reversal of beneficial effects at higher doses. The fact that each single 
phytochemical extends lifespan to a lesser degree than does the whole apple 
extract suggests that a mixture of phytochemicals may be necessary to elicit 
the greatest health benefit. This result is in agreement with previous reports in 
the literature, which suggest that phytochemicals possess synergistic effects 
(4). 
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Figure I.1 Effect of quercetin-3-β-D-glucoside on the lifespan of C. elegans. 
Day 1 young adult wild-type animals were treated without (0 µM) or with 25 
µM, 50 µM or 100 µM of quercetin-3-β-D-glucoside dissolved in .1% DMSO 
(see Section 2.2.5 for methods). Survival was monitored starting on day 1 of 
adulthood. Nematodes, that were exposed to the low and middle dose of 
quercetin-3-β-D-glucoside survived significantly longer than the control (Table 
I.1). The experiment was repeated multiple times and a representative trial is 
shown.
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Table I.1 Effect of quercetin-3-β-D-glucoside on mean lifespan of C. elegans.
Treatment N Mean Lifespan*(days) ∆**
p- 
value 
vs. 
control
% of 
Control
0 µM 89 15.03±.17 a N.A. 100.0
25 µM 78 16.23±.21 b <0.001 108.0
50 µM 69 16.35±.30 b <0.001 108.8
100 µM 71 15.92±.28 b <0.01 105.9
* Mean ± SEM based upon Kaplan-Meier estimator
** Values with no letters in common within each column are significantly 
different; a p-value of < 0.05 was considered to be statistically significant 
based on chi-squared log-rank test).
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Figure I.2 Effect of 2-α-ursolic acid on the lifespan of C. elegans. Day 1 young 
adult wild-type animals were treated without (0 µM) or with 25 µM, 50 µM or 
100 µM of 2-α-ursolic acid dissolved in .1% DMSO (see Section 2.2.5 for 
methods). Survival was monitored starting on day 1 of adulthood. Nematodes, 
that were exposed to the low and middle dose of 2-α-ursolic acid survived 
significantly longer than the control (Table I.1). The experiment was repeated 
multiple times and a representative trial is shown.
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Table I.2 Effect of 2-α-ursolic acid on mean lifespan of C. elegans.
Treatment N Mean Lifespan*(days) ∆**
p- 
value 
vs. 
control
% of 
Control
0 µM 98 16.06±.17 a N.A. 100.0
25 µM 96 16.70±.22 c 0.023 104.0
50 µM 66 15.45±.20 c 0.020 96.2
100 µM 90 15.83±.10 c 0.283 98.6
* Mean ± SEM based upon Kaplan-Meier estimator
** Values with no letters in common within each column are significantly 
different; a p-value of < 0.05 was considered to be statistically significant 
based on chi-squared log-rank test).
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Figure I.3 Effect of apple extracts on the lifespan of N2 wild-type C. elegans 
done in parallel to lifespan experiments with quercetin-3-β-D-glucoside and 2-
α-ursolic acid. Day 1 young adult wild-type were treated without (0 mg/mL) or 
with a low (2.5 mg/mL) and moderate (5 mg/mL) dose of standardized apple 
extracts, which contained 170 ± 4.6 mg of phenolics per 100 g of apples. 
Survival was monitored starting on day 1 of adulthood. Nematodes, that were 
exposed to two levels of apple extracts survived significantly longer than those 
that did not (p<0.001 for 0 mg/mL compared to each treatment group; log-rank 
test; see Table I.3) The experiment was repeated multiple times and a 
representative trial is shown.
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Table I.3 Effect of apple extracts on the mean lifespan of N2 wild-type C. 
elegans done in parallel with quercetin-3-β-D-glucoside and 2-α-ursolic acid. 
Treatment N Mean Lifespan*(days) ∆**
p- 
value 
vs. 
control
% of 
Control
0 mg/mL 50 15.768±.29 a N.A. 100.0
2.5 mg/mL 41 20.47±.62 b <0.001 108.0
5 mg/mL 61 20.894±.43 b <0.001 108.8
* Mean ± SEM based upon Kaplan-Meier estimator
** Values with no letters in common within each column are significantly 
different; a p-value of < 0.05 was considered to be statistically significant 
based on chi-squared log-rank test).
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Appendix II
Additional statistical analysis of One-way ANOVA experiments (Minitab). 
II.1 Attenuation of Lipofuscin 
Factor  Type   Levels  Values
Conc    fixed       4  0.0, 2.5, 5.0, 16.0
Analysis of Variance for Pump, using Adjusted SS for Tests
Source  DF     Seq SS       Adj SS       Adj MS      F      P
Conc     3  3.69202E+20  3.69202E+20  1.23067E+20  59.41  0.000
Error   80  1.65733E+20  1.65733E+20  2.07166E+18
Total   83  5.34935E+20
S = 1439327604   R-Sq = 69.02%   R-Sq(adj) = 67.86%
Tukey Simultaneous Tests
Response Variable Pump
All Pairwise Comparisons among Levels of Conc
Conc =  0.0  subtracted from:
       Difference       SE of           Adjusted
Conc     of Means  Difference  T-Value   P-Value
 2.5  -3481810051   441329610   -7.889    0.0000
 5.0  -2860427947   462323595   -6.187    0.0000
daf-16 1647724508   473420940    3.480    0.0044
Conc =  2.5  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
 5.0   621382105   422291424    1.471    0.4594
daf-16 5129534559   434412624   11.808    0.0000
Conc =  5.0  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
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daf-16 4508152455   455725366  9.892    0.0000
II.2 Survival of C. elegans after 35°C Heat Shock 
One-way ANOVA: % Alive versus Strain-or-Conc 
Source          DF       SS      MS       F      P
Strain-or-Conc   5  18643.4  3728.7  102.83  0.000
Error           27    979.0    36.3
Total           32  19622.4
S = 6.022   R-Sq = 95.01%   R-Sq(adj) = 94.09%
Level is either N2 on 0 mg/mL or indicated concentration 
of apple extract or indicated strain on 0 mg/mL 
                        Individual 95% CIs For Mean Based on
                        Pooled StDev
Level  N   Mean  StDev  --------+---------+---------+---------+-
 0.0   3  55.71   1.24              (---*--)
 10.0  6  96.13   4.78                                    (-*--)
 2.5   6  71.40   8.07                       (--*-)
 5.0   6  87.17   6.22                               (--*-)
age-1  6  89.73   5.34                                (--*-)
daf-16 6  28.96   6.33  (-*--)
                        --------+---------+---------+---------+-
                               40        60        80       100
Tukey Simultaneous Tests
Response Variable Fluor
All Pairwise Comparisons among Levels of Conc
Conc =  0.0  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
age-1      40.42       4.258    9.492    0.0000
 2.5       15.68       4.258    3.683    0.0117
 5.0       31.46       4.258    7.389    0.0000
10.0       34.02       4.258    7.990    0.0000
daf-16    -26.75       4.258   -6.283    0.0000
Conc =  age-1  subtracted from:
      Difference       SE of           Adjusted
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Conc    of Means  Difference  T-Value   P-Value
 2.5      -24.74       3.477    -7.12    0.0000
 5.0       -8.96       3.477    -2.58    0.1379
10.0       -6.40       3.477    -1.84    0.4582
16.0      -67.17       3.477   -19.32    0.0000
Conc =  2.5  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
 5.0       15.78       3.477     4.54    0.0013
10.0       18.34       3.477     5.27    0.0002
daf-16    -42.43       3.477   -12.21    0.0000
Conc =  5.0  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
10.0        2.56       3.477     0.74    0.9755
daf-16     -58.21       3.477   -16.74    0.0000
Conc = 10.0  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
daf-16   -60.77       3.477   -17.48    0.0000
II.3 Induction of SOD-3 promoter in SOD-3::GFP worms
Factor  Type   Levels  Values
Conc    fixed       4  0.0, 2.5, 5.0, 10.0
Analysis of Variance for Fluor, using Adjusted SS for 
Tests
Source  DF   Seq SS   Adj SS  Adj MS      F      P
Conc     3  14.5240  14.5240  4.8413  12.86  0.000
Error   53  19.9596  19.9596  0.3766
Total   56  34.4837
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S = 0.613675   R-Sq = 42.12%   R-Sq(adj) = 38.84%
Tukey Simultaneous Tests
Response Variable Fluor
All Pairwise Comparisons among Levels of Conc
Conc =  0.0  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
 2.5      -1.211      0.2187   -5.537    0.0000
 5.0      -1.235      0.3392   -3.642    0.0034
10.0      -0.910      0.1971   -4.616    0.0002
Conc =  2.5  subtracted from:
      Difference       SE of            Adjusted
Conc    of Means  Difference   T-Value   P-Value
 5.0    -0.02463      0.3479  -0.07080    0.9999
10.0     0.30100      0.2117   1.42155    0.4918
Conc =  5.0  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
10.0      0.3256      0.3348   0.9726    0.7655
II.4 Induction of GST-4 promoter in GST-4::GFP worms
Factor  Type   Levels  Values
Conc    fixed       4  0.0, 2.5, 5.0, 10.0
Analysis of Variance for Fluor, using Adjusted SS for 
Tests
Source   DF   Seq SS   Adj SS  Adj MS     F      P
Conc      3   6.4708   6.4708  2.1569  6.37  0.001
Error   111  37.5665  37.5665  0.3384
Total   114  44.0372
S = 0.581753   R-Sq = 14.69%   R-Sq(adj) = 12.39%
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Tukey Simultaneous Tests
Response Variable Fluor
All Pairwise Comparisons among Levels of Conc
Conc =  0.0  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
 2.5     -0.1294      0.1510   -0.857    0.8267
 5.0     -0.5421      0.1495   -3.627    0.0024
10.0     -0.5034      0.1510   -3.335    0.0063
Conc =  2.5  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
 5.0     -0.4127      0.1569   -2.630    0.0473
10.0     -0.3740      0.1583   -2.362    0.0906
Conc =  5.0  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
10.0     0.03868      0.1569   0.2465    0.9947
II.5 Induction of Hsp16.2 promoter in Hsp16.2::GFP worms
Factor  Type   Levels  Values
Conc    fixed       2  0, 10
Analysis of Variance for Fluor, using Adjusted SS for 
Tests
Source  DF  Seq SS  Adj SS  Adj MS      F      P
Conc     1  1688.8  1688.8  1688.8  12.98  0.002
Error   19  2471.3  2471.3   130.1
Total   20  4160.1
S = 11.4048   R-Sq = 40.59%   R-Sq(adj) = 37.47%
Tukey Simultaneous Tests
Response Variable Fluor
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All Pairwise Comparisons among Levels of Conc
Conc =  0  subtracted from:
      Difference       SE of           Adjusted
Conc    of Means  Difference  T-Value   P-Value
10       18.12       5.029    3.603     0.0019
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